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ER protein homeostasis plays an important role in normal organism 
physiological and pathological conditions. ER stress induces activation of the 
unfolded protein response, which reacts to reset ER homeostasis by enhancing 
protein folding capacity, reducing protein translation load and up-regulating ER 
associated degradation. It is important to understand the physiological role of each 
main UPR or ERAD component as well as their molecular regulatory 
mechanisms. 
IRE1α, the most conserved UPR sensor protein, is a bifunctional enzyme 
containing both a kinase and RNase domain that are important for trans-
autophosphorylation and Xbp1 mRNA splicing, respectively. However, the amino 
acid residues important for structural integrity remain largely unknown. This 
research has identified a highly conserved proline residue at position 830 (P830) 
that is critical for IRE1α structural integrity, hence the activation of both kinase 
and RNase domains. Further structural analysis reveals that P830 could form a 
highly conserved structural linker with adjacent tryptophan and tyrosine residues 
at positions 833 and 945 (W833 and Y945) thereby bridging the kinase and 
RNase domains. This finding may facilitate the identification of small molecules 
which specifically compromise IRE1α function. 
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Previously, ER stress has been shown to activate inflammatory responses. 
Yet, whether this is true with ERAD in vivo remains to be demonstrated. Using 
macrophage-specific Sel1L (a key protein component of the Sel1L-Hrd1 ERAD 
complex) knock-out mice, our data challenges the causal link between ER stress 
and inflammation in a physiological setting. This research shows that Sel1L is 
dispensable for normal macrophage innate immunity functions. Although these 
macrophages exhibited elevated protein levels of a subset of ER chaperones and 
dilated ER cisternae at the basal conditions, surprisingly these changes are 
uncoupled from macrophage antigen presenting function, cytokine secretion 
function, and inflammatory responses against bacterial pathogens as well as in 
obese adipose tissues. Thus, we conclude that physiological mild ER stress may 
not play a causal role in inflammation in macrophages.  
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Chapter 1 INTRODUCTION AND LITERATURE 
REVIEW 
 
1.1 THE ENDOPLASMIC RETICULUM 
All eukaryotic cells have an endoplasmic reticulum (ER). It is organized by 
interconnected flattened sacs and tubules and is continuous with the outer nuclear 
membrane. Thus, the ER membrane and the outer nuclear membrane form an 
enclosing internal space, called the ER lumen or the ER cisternal space, which 
often occupies more than 10% of the total cell volume. 
 
The ER is structurally and functionally diverse among different cell types in 
order to meet diverse functional demands. Even within a cell, distinct regions of 
the ER may be highly specialized. In general, the ER is divided into rough ER and 
smooth ER. Mammalian cell proteins are translated in the cytosol. Secretory 
proteins or membrane proteins are then cotranslationally transported to the ER 
(1). Electron microscopy shows membrane-bound ribosomes coating the surface 
of the ER; therefore these regions are termed rough ER. Regions that lack 
membrane-bound ribosomes are termed smooth ER. Some smooth ER and 
transitional ER (the parts of ER between the rough and the smooth ER) form buds 
off vesicles carrying newly synthesized proteins of lipids for transportation to the 
Golgi apparatus where proteins are further modified. 
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The first and major function of the rough ER is protein sorting, where proteins 
become fully folded, maturated, modified, and transported to their destined 
locations: plasma membrane, lysosomal vesicles or extra-cellular space. This 
process requires abundant protein chaperones that assist protein folding and 
quality control. The main function of smooth ER lies in lipid metabolism. The ER 
membrane synthesizes nearly all the major classes of lipids -- for example 
phospholipids and cholesterol. The second ER function is lipogenesis, because the 
enzymes that synthesize the lipid components of the lipoprotein particles are 
located in the membrane of the smooth ER. The third function of ER is calcium 
storage. A Ca2+ pump transports Ca2+ from the cytosol into the ER lumen where a 
high concentration of Ca2+ binding proteins facilitates calcium storage. Following 
many rapid responses to extracellular signals, a release of Ca2+ from the ER to the 
cytosol initiates important physiological reactions -- for example -- myofibril 
contraction in the muscle cells. 
 
 Approximately one-third of cell’s proteins are secretory or membrane 
proteins that rely on ER for protein sortation (1). Previous studies have 
established the Signal Recognition Particle (SRP) pathway for ER resident or 
secretory proteins (2-5). Newly exported mRNAs yield the synthesis of an N-
terminal signal sequence that is recognized by the SRP which suppresses protein 
synthesis. The ribosome-nascent polypeptide-SRP complex is recruited to the ER 
via binding interactions with the ER resident SRP receptor. Upon binding of the 
SRP receptor, SRP is released, translation resumes and the growing peptide is 
cotranslationally translocated into the ER. 
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ER plays a significant role in the expression of the mRNA transcriptome. 
Previous studies have demonstrated an enhanced half-life for ER-associated 
mRNA (6). Additionally, ER-associated mRNAs are excluded from the stress 
granule-directed trafficking pathways (7). Recently, studies on the mRNA 
translation and partitioning have further revealed the importance of ER in protein 
synthesis. Nicchitta’s lab has reported two primary observations based on cell 
fractionation and ribosome profiling (8, 9): First, mRNAs encoding cytosolic 
proteins were broadly represented in the ER ribosome-associated mRNA pool and 
second, steady-state ribosome loading on ER-bound mRNAs was substantially 
higher than in the cytosol. These findings suggest that the ER might serve as a 
preferred locale for the synthesis of proteins. The existence of two compartments 
(ER and cytosol) in protein translation indicates that many RNA-binding proteins 
modulate a wide range of post-transcriptional processes (10) and confer 
compartment-specific translational efficiency (11); therefore, they are 
compartmentally segregated between cytosolic and ER-bound polysomes. 
 
1.2 PROTEIN HOMEOSTASIS 
1.2.1 Protein synthesis 
Protein synthesis is operated by ribosomes. At the AUG start codon on the 5’ 
end of mRNA, the large (60S) and the small (40S) ribosomal subunits form an 
initiation complex. Transfer tRNAs donate amino acids to elongate nascent 
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polypeptides at a rate of ~4-5 amino acids/second in mammalian cells (12). At the 
3’ end of mRNA, when a stop codon (UAG/UGA/UAA) is read, the large and 
small subunits of ribosomes disassemble and so translation stops. Translation has 
an error rate of about 1 amino acid in 103-104 (13-16). In addition to a high error 
rate in protein translation and transcription, proteins destined for the plasma 
membrane, lysosomal or extracellular space are folded in the ER at a 2.5-4 times 
faster rate than proteins synthesized in the cytosol (17). These ER dependent 
proteins also require more modifications to create structural complexity, thereby 
requiring the complicated regulation and quality control system discussed below.  
 
1.2.2 Chaperone-assisted protein folding in the ER 
The ER houses factors that assist protein folding and maturation in a 
challenging environment -- high concentrations of calcium ions and oxidizing 
conditions. Classical chaperones are grouped in several subfamilies: Hsp40, 60, 
70, 90 and 100 kDa in size (18). Their synthesis is strongly enhanced under 
conditions of ER overload, glucose deprivation, and disruption of calcium or 
redox homeostasis (19, 20). BiP, for example, also known as GRP78 protects 
immature proteins from aggregation by binding to extended hydrophobic domains 
with relatively low affinity (1-100 mM) (18). BiP also plays an important role in 
the preparation of terminally misfolded ER proteins for dislocation into the 
cytosol for degradation (21-24); BiP also contributes to the unfolded protein 
response (25). 
 
  
 
 
 
 
5 
1.2.3 Lectins and protein quality control in the ER 
Glycosylated proteins are decorated with a preassembled oligosaccharide core 
N-acetylglucosamine2-mannose9-glucose3 (Glc3Man9GlcNac2) at selective 
asparagine (N) residues (in Asn-X-Ser/Thr consensus site) by the 
oligosaccharyltransferase (OST) from a lipid pyrophosphate donor on the ER 
membrane, dolichol-PP (26, 27). After peptide translocation, the -glucosidases 
I and II remove the two outermost glucose residues to produce a mono-
glucosylated core glycan (28). Then two homologous ER lectins, calnexin (CNX) 
and calreticulin (CRT), in association with ERp57, an oxidoreductase that 
catalyzes disulfide bond formation, interact with the substrate to perform protein 
folding (29). Once folded, the innermost glucose residue is rapidly removed by 
glucosidase II while mis-folded or non-native deglucosylated glycoproteins are 
recognized by the ER folding sensor UDP-glucose:glycoprotein 
glucosyltransferase (UGT1) (30). UGT1 specifically re-glucosylates folding 
intermediates released from the CNX/CRT cycle so they will remain in the ER to 
enter more rounds of CNX/CRT-assisted folding. These additional rounds of 
CNX/CRT-assisted folding serve to delay aggregation and loss of folding 
competence (31, 32). This process is called the CNX/CRT cycle. The substrates 
that fail to acquire their native well-folded structure are eventually cleared by ER-
associated degradation (ERAD) (33). In contrast, properly folded proteins 
released from CNX/CRT are transported to the Golgi compartment and assisted 
by mannose-binding lectins, such as ERGIC-53, VIPL, ERGL (34, 35). 
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Although in cultured cells, a single deletion of a single chaperone does not 
cause evident ER stress (36, 37), in vivo whole-body deletion of ER components 
such as ERP57 (38) or calreticulin (39, 40) results in embryonic lethality in mice. 
Calnexin-deficient mice displayed obvious motor disorders associated with a 
dramatic loss of large myelinated nerve fibers (41). The physiological functions of 
a specific type of chaperone or lectin are probably tissue-specific or specific 
during the development period (41, 42). MHC class I molecules expressed in a 
calreticulin-deficient cell line exhibited defective peptide loading and impaired T 
cell recognition (38, 43). These results all indicate the importance of lectins in 
maintaining normal ER homeostasis in cellular physiology. 
 
1.2.4 Disulfide bond formation  
The formation of disulfide bonds also serves to stabilize ER proteins. The 
incorrect pairing of cysteine residues usually prevents the folding of a protein into 
its native conformation (44). Prokaryotic and eukaryotic cells share similar 
pathways of disulfide-bond formation. In eukaryotic cells, protein disulfide -
bonds are predominantly formed in the lumen of the ER. In vivo, the most 
common mechanism for the formation of protein disulfide bonds is a thiol- 
disulfide exchange reaction (44). Protein disulfide isomerase (PDI) was one of the 
first-identified thiol- disulfide oxidoreductases (45, 46) (47). Individual PDI 
homologues facilitate the maturation of discrete sets of proteins and they might 
also differ in their redox activity within the cell. Additionally, ERP57, a PDI 
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family member, acts in a unique pathway together with calnexin and calreticulin 
to assist in the maturation of a class of glycoproteins (48, 49). 
 
1.2.5 Substrate-specific chaperones 
While most proteins can be well folded by the traditional chaperone and 
lectins system, other proteins require a subgroup of specific chaperones for proper 
folding and maturation due to their unique expression levels or protein structure. 
For example, an LDL receptor needs the assistance of Receptor-Associated 
Protein (RAP) to prevent aggregation and premature ligand binding when being 
escorted to the Golgi (50, 51). Collagen also requires Hsp47 for its proper 
maturation in the ER (52) because Hsp47 mice display collagen deficiency and 
premature death (53). 
 
1.2.6 Protein sorting from the ER 
The ER proteins that are destined for the Golgi apparatus or beyond are 
transported in the form of COP-II coated vesicles. Proteins must be properly 
folded in order to exit from the ER. Despite the unclear mechanism of ER luminal 
protein transportation to the Golgi apparatus, it is known that many membrane 
proteins are actively concentrated in the specialized ER regions called ER exit 
sites. As vesicles bud from the ER, they start to merge with other vesicles that 
have matching SNARES. The clusters are moved quickly along microtubules to 
the Golgi apparatus while selective proteins with ER retrieval signals (KKXX 
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sequence at the C-terminal end for membrane proteins or KDEL sequence at the 
C-terminal end for soluble ER proteins) are returned to the ER through vesicles 
coated with COPI.  
 
The Golgi apparatus is a polarized organelle consisting of cis, medial and 
trans cisternae. Proteins and lipids move from the cis to the trans cisternae by 
vesicular transport, by progressive maturation of the cis cisternae migrating 
continuously or, most likely, by a combination of the two mechanisms. The Golgi 
apparatus contains many sugar nucleotides and glycosyl transferase enzymes. 
Proteins undergo further glycosylation reactions and modifications, e.g. the O-
linked (Pyrrolysine-linked) glycosylation occurs within the Golgi. N-linked 
(Asparagine-linked) oligosaccharides glycosylation initially occurs in the ER and 
the oligosaccharides are usually removed in the Golgi. The finished protein in the 
trans- Golgi will be packed into vesicles and further transported into destined 
locations: lysosome, plasma membrane or extracellular space. 
 
Terminally misfolded proteins in the ER are removed to the cytosol where 
they are degraded by the ubiquitin-proteasome system. This process is called ER-
associated degradation (ERAD) (54). It is used for physiological protein turnover 
and is also utilized by viruses for structural protein breakdown. ERAD is an 
important aspect of the protein quality control system. The details will be 
discussed in 1.4. 
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1.2.7 ER STRESS 
The ER protein homeostasis is maintained at a dynamic state of balance in 
which the input of newly synthesized proteins and the export of mature proteins, 
or degradation of misfolded proteins, remain equal. Accumulation of misfolded 
proteins in the ER causes ER stress. Two main mechanisms are adopted by the 
cells to maintain ER protein homeostasis: the unfolded protein response (UPR) 
and the ER associated degradation (ERAD) (Figure 1.1). The unfolded protein 
response (UPR) is activated to enhance protein folding machineries for the 
purpose of increasing protein output from the ER. UPR is also activated to 
attenuate protein translation in order to reduce the accumulation of misfolded 
proteins. The details of unfolded protein response (UPR) will be discussed in 1.3. 
The ERAD components can also be enhanced by UPR signaling pathways. 
Activation of ERAD will lead to ER protein translocation into the cytosol where 
these proteins are degraded by the cytosolic proteasome system. The details of 
ERAD will be discussed in 1.4. 
 
ER stress can be caused by multiple physiological or pathological conditions: 
nutrient deprivation (55), virus infection (56) or calcium depletion (57). Most of 
the time, ER stress is caused by mutations of ER proteins such as anti-trypsin (58) 
or Parkin (59). The most common ER stress inducing drugs include thapsigargin 
(Tg), which inhibits ER calcium transport ATPase (60), tunicmycin (Tm), which 
blocks protein glycosylation (61) and dithiothreitol (DTT) which disrupts 
disulfide bond formation. 
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Figure 1.1  Mechanisms which maintain ER protein homeostasis. 
The ER protein homeostasis is maintained by a balance between the protein 
input into the ER and the protein output for transportation or degradation. An 
accumulation of misfolded proteins in the ER leads to ER stress accompanied by 
increased levels of protein chaperones and lectins in the ER. The unfolded protein 
response (UPR) and the ER associated degradation (ERAD) are the two major 
mechanisms which reduce ER stress. Activation of UPR enhances ER protein 
folding machineries and attenuates protein translation. ERAD activation promotes 
protein translocation into the cytosol where the proteins are degraded by the 
proteasomes. 
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1.3 THE UNFOLDED PROTEIN RESPONSE (UPR) 
In response to ER stress, organisms have developed an evolutionarily 
conserved ER-to-nucleus signaling pathway. The pathway is called the unfolded 
protein response (UPR) and copes with the stress for survival (62). The activation 
of UPR promotes protein export and reduces input by up-regulating ER protein 
folding capacity, enhancing ER-associated degradation, attenuating global 
translation, or inducing apoptosis when the stress is irreversible (63). IRE1α-
XBP1, PERK, and ATF6 pathways are known to mediate unfolded protein 
response in mammalian cells. 
 
1.3.1 IRE1α PATHWAY 
Inositol requiring kinase 1 α (IRE1α) is the most conserved UPR pathway as it 
is the only identified UPR initiation protein in yeast (64, 65). IRE1α is a type I 
transmembrane protein that consists of four major domains: an N-terminal 
luminal sensor domain, a single transmembrane domain, a C-terminal cytosolic 
kinase domain and an endoribonuclease (RNAse) domain. The schematic figure 
of IRE1α protein is shown below (Figure 1.2).  IRE1α knock-out mice exhibited 
embryonic lethality after 12.5 days of gestation (66). IRE1α has a homolog which 
is IRE1β. IRE1β is expressed selectively in the digestive tract and plays a 
distinctive role in mucin-secreting goblet cells. IRE1β knock-out mice showed 
aberrant mucin 2 (MUC2) accumulating in the ER of goblet cells. The mice also 
showed ER distension and elevated ER stress which signaled increased XBP1 
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mRNA splicing (67). Most studies of the mammalian UPR signaling pathway are 
focused on IRE1α. Activation of IRE1α kinase and RNase domain cleaves XBP1 
mRNA (X-box binding protein 1) (1.3.1.1), mediates mRNA decay (1.3.1.2), 
regulates inflammatory signaling pathways and determines cell fate  (1.3.1.3) 
(Figure 1.3).  
 
Figure 1.2 Schematic figure of IRE1α 
IRE1α is composed of an N-terminal luminal sensor domain, a single 
transmembrane domain and C-terminal cytosolic kinase domain and an 
endoribonuclease (RNAse) domain. The numbers of the amino acids indicate the 
position of each domain. 
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Figure 1.3 Mammalian IRE1α signaling pathways 
Under ER stress conditions, BiP disassociates from the IRE1α luminal domain 
and then monomers of IRE1α undergo oligomerization, phosphorylation and 
conformational changes that expose the active nuclease sites. Activated IRE1α 
RNase domain cleaves XBP1 mRNA. The spliced form -- XBP1s -- is translated 
into a transcriptional factor that enhances protein folding machineries and ERAD. 
Regulated IRE1α-dependent mRNA decay (RIDD) reduces protein load in the ER 
under ER stress. Activated IRE1α can also form a complex with TRAF2 and 
ASK1 to induce JNK and MAPK pathways that regulate inflammatory responses 
and determine cell fate. IRE1α also induces apoptosis through the caspase 
signaling by degrading miR-17/-34a/-96/-125b.  
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1.3.1.1!The!physiological!role!of!IRE1α3XBP1s!signaling!pathway!
Upon activation, IRE1α can function as an endoribonuclease that cleaves a 
unique mRNA called XBP1 (X-box binding protein 1) in metazoans. After the 
cleavage at two specific positions franking an intron, the exons are then ligated to 
form XBP1s mRNA which is translated into XBP1s protein. Splicing of XBP1 
mRNA cuts out 26 nt and results in a frame shift at 165 aa. Hereafter, unspliced 
XBP1u and spliced XBP1s encode proteins of 261 and 376aa respectively (68). 
XBP1s binds to CRE-like sequences. The function of XBP1u is not fully 
understood yet. XBP1u contains a C-terminal degradation domain and a nuclear 
exclusion signal. It is known that XBP1u forms a complex with XBP1s. The 
complex can be transported to cytosol and rapidly degraded by the proteasome 
because of the degradation motif of XBP1u. Therefore, XBP1u may serve as a 
negative regulator of XBP1s (69). 
 
XBP1s is a transcription factor that contributes to lipid biosynthesis, ER 
expansion, chaperones that enhance protein folding, ERAD and secretory 
pathways. Studies with XBP1 knock-out mice show that it is required for cardiac 
myogenesis, hepatogenesis, plasma cell differentiation and for the development of 
secretory tissues (70-73). XBP1 targets a diverse range of genes. These genes 
include (74): 1) In UPR pathways, ER chaperones and ERAD components such as 
ER degradation enhanced mannosidase alpha-like 1 (EDEM1), DnaJ/Hsp40 
homolog subfamily B member 9 (ERDJ4/DNAJB9) and DnaJ/Hsp40 homolog 
subfamily C member 3 (P58IPK/DNAJC3). 2) Tissue specific metabolic genes. 
For example, Mist 1 in skeletal muscles, C/EBPα in adipocytes and lipogenic 
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genes in hepatocytes are all XBP1s targets. 3) Disease-associated genes. For 
example several targets are linked to neurodegenerative diseases (e.g. Cdk5, 
Cdk5rap3, and Sil1) and myodegenerative diseases (e.g. Als2, Lmna, and Mbnl2). 
Specifically, γ-secretase complex components Ncstn, Psen1 and Psenen are 
involved in processing the amyloid precursor protein (APP) to generate amyloid 
beta peptide (Aβ). 4) Metabolic genes including those that regulate glycosylation, 
carbohydrate metabolism, glycolysis, gluconeogenesis, lipid and fatty acid 
metabolism, and apoptosis/cell survival. 5) Regulators of gene expression and 
chromosomal architecture, cell growth and differentiation, RNA processing and 
export, signal transduction, ubiquitin-associated processes, ion channels, 
transporters and proton pumps as well as DNA replication and repair, redox 
homeostasis and oxidative stress response. These functional targets suggest that 
XBP1 plays dual roles in both adjusting to the increased demand from the 
biosynthesis in the ER and neutralizing the byproducts produced in the process.  
 
1.3.1.2!Regulated!IRE1α3dependent!mRNA!decay!(RIDD)!
IRE1α independently mediates the rapid degradation of a specific subset of 
mRNAs (75). This function is processed by direct IRE1α endonucleolytic 
cleavage, since IRE1α showed a reduced specificity similar to its closest 
homolog, ribonuclease (RNase) L (76). Alternatively, IRE1 may rapidly recruit or 
activate a second ribonuclease. IRE1α may also promote translational stalling and 
cleavage by no-go decay (75, 77). The substrates of RIDD are divergent in 
eukaryotes. RIDD operates only in fission yeast, but not in budding yeast, and it is 
  
 
 
 
 
16 
the only identified mechanism of UPR in fission yeast (78). Detailed mechanisms 
of RIDD are still unknown and require further investigation. 
 
Recently it has been discovered that sustained IRE1α RNAse activity causes 
rapid decay of microRNAs (miR-17, 34a, 96 and 125b) that normally repress 
caspase-2 mRNA (79), therefore inducing apoptosis. The molecular mechanisms 
and implications of microRNAs and ER stress response await further 
investigation.  
 
1.3.1.3!IRE1α!is!a!cell!fate!determinant!
IRE1α was not only identified as a positive regulator of cell survival but was 
also identified as a regulator of stress-induced apoptosis through cross talk 
between the ER and mitochondria. First, Bax-inhibitor 1 (BI-1/Tmbim6) is a 
highly conserved multi-transmembrane protein that resides predominantly in the 
ER. It serves to suppress IRE1α kinase and endoribonuclease activity. This 
suppression has implications for controlling cell death and autophagy (80). 
Second, when attempts to restore ER protein homeostasis fail, IRE1α can 
represses adaptive responses (81-83) and activate apoptosis through IRE1α 
dependent degradation of miR-17/-34a/-96/-125b, thereby up-regulating Caspase 
2 (84). Third, IRE1α stimulates activation of the Apoptotic-Signaling Kinase-1 
(ASK1) through formation of an IRE1-TRAF2-ASK1 complex (85). ASK1 
activates the c-Jun N-terminal kinase (JNK) and the p38 MAPK kinase which, in 
turn, signal cascades that promote ROS-induced apoptosis in a mitochondria-
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dependent pathway (86). ASK1 also plays a role in cell adaptation by opposing 
various stresses (86). Moreover, ER stress induces activation of mTORC1, which 
reduces AKT phosphorylation and induces activation of IRE1-JNK pathway and 
apoptosis (87). 
 
Among the apoptosis-inducing substrates of JNK are two members of the 
BH3-only subgroup of Bcl2-related proteins, Bim and Bmf, which are normally 
sequestered by binding to dynein and myosin V motor complexes. Once 
phosphorylated by JNK, Bim and Bmf are released from the motor complex and 
induce Bax/Bak-dependent mitochondrial apoptosis (88). Bax and Bak also 
function in the ER membrane and bind to the cytosolic domain of IRE1α for 
activation (89). In addition, the transcription factor CHOP is downstream of 
IRE1α and regulates apoptosis. This regulation functions in part by enhancing 
DR5 (90) and Bim (91) while directly inhibiting Bcl-2 transcription (92, 93). 
Therefore, IRE1α closely interact with BCL-2 family proteins in regulating stress-
induced apoptosis through a cross talk between the ER and mitochondria. 
 
1.3.1.4!IRE1α!activation!mechanism!
IRE1α is activated upon sensing the accumulation of unfolded proteins in the 
ER. The activation process of IRE1α can be divided into several steps: the 
luminal domain sensing the ER stress; auto-phosphorylation; oligomerization and 
conformational change. For the ER stress sensing mechanism, the N-terminal 
luminal region of yeast IRE1α is composed of five sub-regions, termed I-V, 
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extending from the N-terminus to the transmembrane region (94). When the core 
luminal domain (cLD) binds to unfolded proteins or to peptides that are primarily 
composed of basic and hydrophobic residues (95), dimerization and 
oligomerization of IRE1α occur, mediated by subregions II-IV interacting as 
homodimers (96). The homodimer formation can be impaired by an internal 
deletion on subregion IV S103P mutation (96). S103P mutation on the luminal 
domain of yeast IRE1α led neither to BiP dissociation nor to a change in self-
association. However, S103P mutant IRE1α remained constitutively activated 
upon ER stress, indicating that self-association and BiP dissociation are not 
required for activation of yeast IRE1α (97). Analysis of the yeast IRE1α crystal 
structure revealed that the core luminal domain dimerizes to form a shared central 
groove, and its architecture is similar to the peptide binding domains of major 
histocompatibility complex (MHC). Therefore, it is proposed that the cLD 
directly binds unfolded proteins, which changes the conformational structure of 
IRE1α monomers and in turn positions the cytosolic kinase domains prone to 
autophosphorylation (98). On the contrary, the mammalian IRE1α binds to BiP at 
basal conditions, and the activation of IRE1α is strongly dependent on the 
disassociation of BiP (99). Recently, it has been proved that BiP provides a buffer 
system against mild stress because BiP binding accelerates IRE1α deactivation 
and deoligomerization. Therefore BiP modulates the sensitivity and kinetics of 
IRE1α (94, 100). Unlike mammalian IRE1α, the luminal domain of its homolog 
IRE1β does not interact with BiP, but it interacts with unfolded proteins instead 
(101). 
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Once sensing the ER stress signal, either by direct binding to unfolded 
proteins or by disassociation of BiP, interactions between cLD initiate dimer 
formation which is required to configure higher-order oligomers necessary for 
UPR activation (98). It was also reported that the dimer contained an 
intermolecular disulfide bond formation (102). The dephosphorylated cytosolic 
portion of the crystal structure of human IRE1α, when bound with ADP, showed a 
face-to-face dimer complex which was distinct from the back-to-back yeast 
IRE1α dimer conformation (103). Transient dimer, or oligomerization, positions 
the kinase domain for trans-autophosphorylation among the adjacent IRE1α 
activation loops. It also orders the RNase domain to form an interaction surface 
which is required for the Xbp1 specific ribonuclease activity (103, 104). In 
mammalian cells, higher orders of IRE1α oligomers were found to comprise four 
or eight IRE1α molecules (105). Yet it is still believed that dimer rather than 
oligomer is the basic functional unit of IRE1α activation, because loss of foci 
formation only delays downstream signaling (106).  
 
IRE1α foci formation upon ER stress can be visualized by attaching a GFP tag 
to a IRE1α expressing plasmid. With TM treatment, 293T cell IRE1α starts foci 
formation after two hours and reaches a peak after four hours with fewer and 
larger foci. After six hours, IRE1α foci start to dissociate and vanish completely at 
eight hours. Interestingly, IRE1α phosphorylation, XBP1 mRNA splicing and the 
kinetics of BiP induction all synchronize well with IRE1α foci formation. The 
IRE1α signal attenuates after prolonged ER stress. Attenuation includes cluster 
dissolution, dephosphorylation and a decline in endoribonuclease activity. 
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However, reactivation of IRE1α can still occur after the reset of ER homeostasis 
under additional stimuli (105). 
 
Lipid composition in mammalian membrane phospholipid also serves as an 
important activator of UPR. It has been reported that stearoylCoA desaturase 1 
(SCD1) knockdown causes an increase in the amount of saturated fatty acids and 
a decrease in the amount of monounsaturated fatty acids in phospholipids. This 
process does not affect the amount or the composition of the free fatty acid pool. 
SCD1 knockdown also induces expressions of CHOP and GRP78, and the IRE1α 
mediated splicing of XBP1 mRNA (107). Lipid induced UPR activation can be 
alleviated by treating molecular chaperones (108). This indicates that lipid-
induced ER stress is associated with increased misfolded proteins (109). 
Similarly, cholesterol loading was found to deplete endoplasmic reticulum 
calcium stores, induce UPR, and eventually activate caspase-3 mediated apoptosis 
-- an event likely to promote the progression of atherosclerosis (110). Despite an 
association with increased misfolded protein, the mechanism of IRE1α activation 
(as well as PERK) also lies in an ER-spanning transmembrane domain that may 
directly sense lipid composition of the ER membrane. This is because deletion of 
the IRE1α luminal sensing domain does not repress the responsiveness to ER 
stress induced by increased lipid saturation (111). 
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1.3.2 PERK PATHWAY 
PERK is also a type I transmembrane protein composed of an ER luminal 
stress sensor and a cytosolic kinase domain. The activation mechanism of 
mammalian PERK is similar to that of IRE1α. BiP dissociation from the N-
terminus of PERK initiates homo-dimerization/oligomerization and 
autophosphorylation of the kinase domain (112). Unlike IRE1α, PERK 
phosphorylates the α-subunit of eukaryotic translation initiation factor-2 (eIF2α) 
at Serine 51. This phosphorylation blocks the guanine nucleotide exchange factor 
so eIF2α cannot bind to GTP to form its active state. Instead, it remains bound to 
eIF2B and therefore inhibits translation initiation (113). 
 
Once eIF2α is phosphorylated, a global effect of translation attenuation 
occurs, thus reducing the burden of peptides entering the ER. Furthermore, PERK 
also enhances ERAD and expressions of prosurvival genes such as cIAP (cellular 
inhibitor of apoptosis) (114). However, not all protein translation is attenuated. 
EIF2α phosphorylation promotes translation and expression of ATF4, CHOP and 
BiP. The transcription factor ATF4 drives pro-survival functions and is 
responsible for amino acid import, glutathione biosynthesis and oxidative stress 
resistance (115). Interestingly, ATF4 also induces a transcription factor C/EBP-
homologous protein (CHOP/GADD153). CHOP actively promotes apoptosis 
primarily by repressing Bcl2 and other bZIP transcription factors expression (92). 
CHOP also induces Bcl-2 family protein Bax translocation from cytosol to 
mitochondria (116).  
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PERK is inhibited by P58IPK which binds to the cytosolic kinase domain of 
PERK (117, 118). Alternatively, PERK induces a negative feedback though 
CHOP. CHOP induces GADD34 expression and GADD34 dephosphorylates 
eIF2α by forming a phosphatase with protein phosphatase 1 (PP1) (119). In 
addition, CReP (a constitutive repressor of eIF2α phosphorylation) encodes the 
substrate targeting subunits of two phosphatase complexes that independently 
dephosphorylate eIF2α constitutively (120). With these mechanisms, PERK 
pathway can be rapidly reversed within minutes when ER homeostasis is reset, 
and activated PERK is dephosphorylated (121). 
 
1.3.3 ATF6 PATHWAY 
ATF6 is also a transmembrane UPR initiator with a large luminal domain, a 
transmembrane domain and a cytosolic domain. Upon ER stress, it is transported 
from the ER to the Golgi apparatus where it is sequentially cleaved by S1P (site 1 
protease) and S2P (site 2 protease) to remove the luminal domain and 
transmembrane anchor, respectively (122, 123). For this process, ATF6 shares the 
same protease with sterol response element binding protein (SREBP). After 
cleavage, the remaining cytosolic N-terminal domain of ATF6 is then translocated 
to the nucleus to serve as a transcription factor that up-regulates UPR target genes 
such as chaperones (BiP and Grp94) and protein disulfide isomerase (63). Similar 
to IRE1α and PERK, ATF6 also binds to BiP, and BiP is released under ER stress 
to initiate the ATF6 Golgi localization process (124). In addition, 
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underglycosylated ATF6, in association with Calreticulin, has a higher rate of 
Golgi transportation and activation. This also serves as a mechanism to sense ER 
stress (125). Under basal conditions, ATF6 remains as a monomer, dimer or 
oligomer due to the intermolecular and intramolecular disulfide bonds between 
two conserved cysteine residues in the luminal domain. Upon ER stress, the 
extent of disulfide bond reduction correlates with activation, and only reduced 
ATF6 monomer reaches the Golgi apparatus (126). Details of the ATF6 activation 
mechanism under ER stress remain to be further investigated (63).  
 
Cleaved ATF6, referred to as P50ATF6, (uncleaved ATF6 is of 90KD in size) 
regulates gene transcription in association with other bZIP transcription factors 
and co-regulators. In mammalian systems, the UPR is mediated by the cis-acting 
ER stress response element (ERSE). For example, ERSE mediates the 
transcription factors XBP1 and CHOP induction. The ERSE consensus sequence 
is CCAAT-N9-CCACG (127). Activated ATF6 binds to CCACG when CCAAT 
is bound by the general transcription factor NF-Y/CBF (128). Direct interaction of 
ATF6 and ERSE is critical for transcriptional induction of ER chaperones and 
UPR transcription factors. Recently ERSE-II has been revealed as the second ER 
stress response element; it is composed of ATTGG-N-CCACG. The activation of 
ERSE-II is similarly dependent on ATF6 (128).  
 
Overall, ATF6 induces a cytoprotective gene expression program. ATF6 
upregulates BiP, protein disulfide isomerase (PDI), ER degradation-enhancing 
alpha-mannosidase-like protein 1 (EDEM1), XBP1 (68) and CHOP, etc (121). 
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ATF6 also induces the Regulator of Calcineurin 1 (RCAN1) expression which 
leads to anti-apoptotic activity through Bcl2 and the Bcl2-antagonist of cell death 
(BAD) pathway (129) (130). In addition, there are many ATF6 homologs that are 
processed like ATF6; however, their functions are not yet fully understood. These 
include OASIS, CREBH, LUMAN/CREB3, CREB4, and BBF2H7 (131). In 
addition to protein homeostasis, ATF6(N) also binds to SREBP2(N) and inhibits 
SREBP2 targeted genes in liver cell lipogenesis (132). 
 
Within the inactivation mechanism of ATF6, it is known that XBP1u regulates 
ATF6 degradation. XBP1u has a cytoplasm relocation signal NES and a 
proteasome-mediated degradation signal DEG; both are in the C-terminus of 
XBP1u. XBP1u directly interacts with ATF6 for translocation into the cytosol 
where they are both degraded by the proteasome system (133). 
 
1.4 ER ASSOCIATED DEGRADATION (ERAD) 
Many misfolded proteins are removed from the ER to be degraded by the 
cytosolic proteasome system. This process is called ER-associated degradation 
(ERAD). The major steps of ERAD include: 1) substrate recognition, 2) substrate 
relocation and 3) proteasome degradation (134). A transmembrane complex 
composed mainly of an E3 ligase, together with multiple cofactors, is called an 
ERAD component. Understanding both yeast and mammalian ERAD pathways is 
not enough. The total number of ERAD components remains unclear. Equally 
unclear are the relationships among different ERAD components and the identity 
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of the endogenous substrates for each E3 ubiquitin ligase. This lack of clarity is 
the result of previous research focusing on the model exogenous substrates to 
study their specificity to each ERAD component. 
 
E3 ubiquitin ligases are at the center of ERAD transmembrane complexes. 
The ERAD complexes are responsible for substrate recognition, translocation and 
ubiquitination. The E3s usually have several transmembrane domains with a 
cytosolic RING finger domain (135). They are also associated with cytoplasmic 
AAA-ATPase Cdc48p/p97 that is thought to provide energy for substrate release 
from the ER. In yeast, one conserved E3 ligase complex is composed of E3 ligase 
Hrd1p and ER membrane proteins Der1p. Hrd3p is a substrate recruitment factor 
and is associated with Cdc48p (136). Two additional cofactors, Kar2p and Yos9p, 
are chaperones that can bind to substrates in association with Hrd1p. Another 
yeast E3 ligase is Doa10. Doa10 requires the Ub-conjugating enzymes Ubc6 and 
Ubc7 as well as the Ubc7 cofactor Cue1 and Cdc48 ATPase complex (the AAA-
ATPase Cdc48p, and its cofactors Ufd1 and Npl4) (137, 138). The Cdc48 ATPase 
is only required for degradation of membrane-embedded Doa10 substrates, but 
not for any soluble substrates (137).  
 
In mammalian systems, the ERAD complex is more complicated and diverse 
than that in yeast systems. For E3 ligases, gr78/RNF45/AMFR complex, 
HRD1/Sel1L complex, TCR8 and TEB4 are the known mammalian ERAD 
components, and more are being investigated (139). E2 ligases are also more 
diverse in mammalian systems. Yeast E2 ligase Ubc6 and Ubc7, for example, 
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have two mammalian homologs: Ube2j1, Ube2j2 (140-142) and Ube2g1, Ube2g2 
(59, 143, 144), respectively (139). Similar to the yeast ERAD system, three major 
steps apply to the mammalian ERAD process (Figure 1.4). The details are 
discussed below. 
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Figure 1.4 Three major steps of mammalian ERAD process 
(1) Substrates are folded in the calnexin/calreticulum cycles. If they fail to 
achieve native states or contain lesions, they are recognized by lectins and 
chaperones for ERAD. N-linked glycosylation serves as a marker in this step. A 
variety of known transmembrane E3 ligases are shown in orange in the figure. 
Diversified E2s are indicated in different colors and shapes. HRD1, one of the 
most well known E3 ligases, needs a cofactor, Sel1L, for its own stability and for 
recognizing specific substrates. Lectins and chaperones recognize protein 
substrates and transport them to different E3 ligase complexes. Lectins XTP3-B 
and OS-9 are specifically recognized by HRD1/Sel1L ERAD components. (2) 
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After substrate recognition and targeting, the proteins are translocated through a 
channel composed of Derlin1/2. Herp connects Derlin1/2 translocon to 
HRD1/Sel1L complex. The Ring domain on HRD1 or other E3 ligases add 
ubiquitin to the translocated substrates with the help of ATPase P97. (3) After 
translocation, the protein substrates are finally degraded by 26S proteasomes.   
 
1.4.1 MAJOR STEPS OF ERAD PROCESS 
1.4.1.1!Substrate!Recognition!
Substrates of ERAD include soluble and integral membrane proteins, 
polypeptides that have failed to be post-translationally modified or are otherwise 
damaged or misfolded, and unassembled members of multiprotein complex, as 
well as regular physiological proteins. For example, the cystic fibrosis 
transmembrane conductance regulator (CFTR) relies on the ERAD for regular 
protein turnover and for prevention of toxic protein aggregation (145). 
 
Chaperones, such as the heat-shock protein (Hsp70) family, bind to short 
polypeptide motifs with hydrophobic properties to prevent protein aggregation 
and maintain soluble status. Although molecular chaperones facilitate recognition 
of some ERAD substrates (146, 147), it is still not clear whether the chaperones 
are required for recognition of every ERAD substrate. It is clear though that BiP 
mutant knock-in mice showed defects that were consistent with compromised ER 
quality control and displayed profound brain development defects (148). 
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N-linked oligosaccharide (GlcNAc2-Man9-Glc3) also plays a role in ERAD 
substrate recognition. After the calnexin-calreticulin folding cycle, the 
glycoprotein contains a GlcNAc2-Man9 residue which is a signal for exit from 
ER or transit to its final destinations. On the contrary, if the glycoprotein contains 
hydrophobic patches or is in a molten globule-like state, a glucose molecule will 
be added to the glycoprotein by UDP-glucose:glycoprotein glucosyltransferase 
(UGGT) so it will re-enter the calnexin-calreticulun cycle (149) (150, 151). To 
prevent glycoproteins from becoming permanently trapped in a re-glucosylation 
and folding cycle, mannosidases act as timers. In later ERAD steps, mannosidases 
are required for delivery of certain glycoproteins from EDEM1 to lectins (152, 
153).  
 
Mammalian PDI and its homologs also participate in ERAD substrate 
translocations. PDI enables the retrotranslocation of the cholera toxin and the 
simian virus-40 (SV40) polyoma virus (45, 154). The PDI homologue, ERDJ5 
accelerates formation of the monomer form of null Hong Kong (NHK) from 
disulfide-linked dimers for degradation (155). 
 
1.4.1.2!Substrate!Targeting!
The ERAD system must be able to differentiate among actively folding, fully 
folded or misfolded proteins. It is still not clear how different types of substrates 
are recognized by a subgroup of chaperones followed by different E3 ligase 
complexes. One method is to divide substrates on the site of the misfolded lesion. 
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In yeast, it is hypothesized that there is a sequential check point mechanism to 
determine the destiny of ERAD substrates: if the lesion is in the cytosol (ERAD-
C), then the misfolded protein is targeted for ERAD; if the lesion is in the luminal 
domain (ERAD-L), then the misfolded protein is targeted for the ER-to-Golgi 
transport system (156). Another theory postulates ERAD-L and substrates with 
transmembrane domain lesions (ERAD-M) use Hrd1p/Hrd3p ligase complex. The 
substrate forms a complex together with Der1p via the linker protein Usa1p and is 
recognized by Yos9p (157). ERAD-M differs from ERAD-L in that it is 
independent of Usa1p and Der1p. ERAD-C substrates are directly targeted by 
Doa10p complex for degradation. All three pathways share the Cdc48p ATPase 
complex (158). 
 
Several ER-resident targeting lectins were recently discovered to deliver 
ERAD substrates to the retrotranslocation channel. EDEM (including EDEM1, 
EDEM2 and EDEM3) interacts with calnexin and possibly receives substrates 
from the calnexin cycle (159-164). Yos9 was shown to bind to misfolded proteins 
and form a complex with BiP. Yos9 possibly regulates the selectivity of Hrd1 for 
substrate targeting (157, 158, 165). Yos9p and Hrd3p, having similar 
mechanisms, both serve as “gatekeepers” in recognizing substrates (138). In the 
absence of Hrd3p and Yos9p, overexpression of Hrd1p can still degrade 
substrates. They can bind to substrates for ERAD independent of their 
carbohydrate groups, but still require the site-specific group processed by α-
mannosidase I. Yos9 mammalian homologes, OS9 and XTP3-B were found to 
have similar functions. OS9, interacting with GRP94, recruits NHK for HRD1 
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complex (166). XTP3-B forms a complex with BiP and interacts with 
HRD1/Sel1L (167). 
 
ERAD substrates must be ubiquitylated before degradation by the proteasome 
in the cytosol. The ubiquitylation process involves an E1 ubiquitin-activating 
enzyme, E2 ubiquitin-conjugating enzymes, E3 ubiquitin ligases and, in some 
cases, E4 ubiquitin-chain-extension enzymes (168-170). In yeast, Doa10-
dependent ubiquitylation prefers Ubc6 and Ubc7 (137, 171) whereas Hrd1 uses 
Ubc7.  
 
Mammalian orthologues of E2 ligases are more diverse and the specificity of 
E2 to different substrates and E3 ligases needs further investigation. The 
complexity of E3 is also less studied, and the research is based only on limited 
substrate examples. For instance, F-box only protein (SCF) E3 complex binds to 
glycosylated substrates and affects the stability of the α-subunit of TCRα (172). 
GP78, in cooperation with RMA1, promotes the ubiquitylation of the mutant 
CFTR as an E4-like activity for ERAD (173). Parkin, another E3 ligase, works 
with UBC6 and UBC7 homologues and ubiquitylates a putative G protein-
coupled transmembrane polypeptide named Pael receptor. The Pael receptor 
interacts with Parkin and is responsible for automosal recessive juvenile 
Parkinsonism (ARJP) (59). 
 
Apart from lectins and E2 as important cofactors for substrate targeting, there 
are other important cofactors controlling E3-substrate interactions. Hrd3p in yeast 
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and its metazoan counterpart SEL1L are the most thoroughly characterized 
adaptors and will be discussed more in depth in 1.4.4. Housekeeping chaperones 
Hsp70 and Ssa1p facilitate substrate interaction with Doa10p (174). Hsp70s and 
Kar2p interact with Yos9p-Hrd3p (157). In mammals, BiP interacts with OS-
9/XTP3-B/Sel1L complex (167). 
 
Interestingly, E3s are autoubiquitylated and trigger their own degradation. 
Yeast Hrd3p inhibits Hrd1p degradation and ensures Hrd1p is active only in the 
presence of controlled substrate delivery (175). In mammals, transient expressed 
SEL1L is rapidly degraded but is stabilized when HRD1 is coexpressed (175). In 
yeast, Hrd1 oligermerization is also essential for its activity and is regulated by 
Usa1p (176).  
 
1.4.1.3!The!retrotranslocon!
Previously, Sec61α was thought to compose the retrotranslocon channel. 
However, using real-time fluorescence to detect the ERAD substrates, it was 
discovered that retrotranslocation was blocked by antibodies against Derlin-1 but 
not against Sec61α (177). More studies now show that the Derlin family functions 
as the retrotranslocation channel. In yeast, Der1 interacts with a Ubl-domain-
containing protein, the U1 SNP-associating protein-1 (Usa1), which is a Herp 
homologue and forms a complex together with Hrd1 (158). In mammalian 
systems, Derlin-1 associates with different substrates and the inactivation of 
Delin-1 results in ER stress. Derlin-1 interacts with US11, which is encoded by a 
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virus and specifically targets MHC class I heavy chains for export from the ER. 
Moreover, Derlin-1 interacts with VIMP which recruits the p97 ATPase and its 
cofactor (178). Derlin-1 also interacts with US11, which recruits MHC products 
to Derlin-1 (179). Derlin-1 has a rhomboid pseudoprotease domain, and mutation 
of this domain stabilizes NHK at the cytosolic face of the ER without disrupting 
the p97/VCP interaction. Therefore it is proposed that the rhomboid domain is 
responsible for substrate interaction whereas the C terminus of Derlin-1 is 
independently responsible for p97/VCP recruitment (180).  
 
1.4.1.4!Cytoplasmic!extraction!and!proteasome!degradation!
Ubiquitylated substrates can follow multiple dynamically controlled pathways 
to be degraded in the cytosol. The AAA adenosine triphosphatases (ATPase) 
Cdc48p (or p97 in metazoans), or at times the proteasome lid, play an important 
role in the extraction of substrates from the ER membrane (181). Once in the 
cytosol, peptide N-glycanase (PNGase), recruited by p97, removes the N-linked 
glycans from the substrates before entering into the proteasome (182, 183))(184). 
Deubiquitination is also required in the process of dislocation and is processed by 
YOD1 (185). During the entire process, ERAD is tightly coupled to substrate 
dislocation in a complex manner (134). 
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1.4.2 THE CONCEPT OF ERAD TUNING 
It is proposed that a complex comprised of SEL1L and LC3-I acts as an 
ERAD tuning receptor and regulates the COPII-independent vesicle-mediated 
removal of the luminal ERAD regulators EDEM1 and OS-9 from the ER. This 
model suggests that during basal condition, SEL1L disengages and the absence of 
ERAD substrates possibly causes E3 ligase-induced ubiquitylation and 
degradation of the retro-translocon. EDEM1 and OS-9 are segregated in ER-
derived ERAD tuning vesicles with the intervention of SEL1L and LC3-I. 
However during ER stress with accumulated proteins in the ER, elevation of the 
intraluminal levels of ERAD substrates competitively bind Sel1L, thus reducing 
the interaction of SEL1L with EDEM1, OS-9 and LC3-I. The dislocation 
machineries are stabilized, so the intraluminal concentration of ERAD factors and 
ERAD activity are enhanced (186). In short, the ERAD tuning pathways offer 
rapid and readily reversible adaptation response to deal with transient problems 
which may arise in the folding compartment. Activation of UPR, on the other 
hand, requires more time for transcription and translation regulations (186). 
 
The concept of ERAD tuning is based on three pieces of evidence (187): 1) 
Several ERAD factors including ERManI (188, 189), EDEM1 (190-193), OS-9 
(186), XTP3-B (167), HERP (194, 195), SEL1L (196, 197), the E3 ligases 
SMURF1 (198, 199) and gp78 (200, 201), JAMP (202) and ataxin-3 (203, 204) 
are subjected to faster turnover than conventional ER-resident chaperones and 
enzymes. This indicates that they may be involved in the ubiquitin proteasome 
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system, autophagy or autophagy-like pathways. 2) Some ERAD factors are 
constitutively segregated from the ER (186, 205). 3) Luminal expression of 
misfolded polypeptides may delay the turnover of ERAD factors, may retain them 
in the ER by interfering with their vesicle-mediated segregation from the 
compartment, or may directly affect the composition of ERAD complexes and 
their activity (186, 206, 207). 
 
The ERAD tuning theory is also proved in the coronaviruses (including SARS 
and mouse hepatitis virus, MHV) during their infection cycle. The viruses hijack 
components of the ERAD tuning machinery and presumably co-opt EDEM1/OS-
9/LC3-I-containing vesicles for replication (186, 192). 
 
1.5 ER STRESS AND DISEASES 
Increasing numbers of diseases are discovered to be associated with misfolded 
protein accumulation. In many cases, the unfolded protein response is specifically 
activated to reverse the ER stress by enhancing protein folding, ERAD or global 
translation attenuation. The type of diseases that result from mutations that 
interfere with proper protein folding or trafficking are called “conformational 
diseases” (208, 209). These misfolded proteins can lead to the accumulation of 
aggregated forms of the protein which become toxic for the cell (210). Typical 
examples include prion encephalopathies, neurodegenerative diseases 
(Alzheimer’s, Parkinson’s, Huntington’s), type 2 diabetes, amyloidosis, etc. On 
the other hand, when the aberrant conformer of a protein undergoes abnormal 
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degradation by the ubiquitin-proteasome system, it can lead to a loss-of-function 
effect (211). One example of loss-of-function disease is cystic fibrosis which is 
characterized by a loss of the functional Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR) (201, 212, 213).  
 
Chemical chaperones are low molecular weight compounds that stabilize 
proteins in their native conformation. Chemical chaperones are effective in 
rescuing processing defects in the mutant protein. They can inhibit protein 
aggregation and enable the mutant proteins to escape the quality control systems 
(214). Compounds such as receptor ligands or enzyme inhibitors that selectively 
recognize the mutant proteins were found to rescue conformational mutants and 
were termed pharmacological chaperones (215-217). Increasing evidence has 
suggested that chemical and pharmacological chaperones could be effective in 
treating conformational diseases (218). In this introduction, I will focus on 
metabolic and immune conformational diseases. 
 
1.5.1 ER STRESS AND METABOLIC DISEASES 
1.5.1.1!ER!stress!and!obesity!and!diabetes!
UPR has been proposed as the intermediate link between obesity and diabetes. 
ER stress has been shown to exist in metabolic tissues, mostly liver, pancreas and 
adipose tissues. Activation of the IRE1α-JNK pathway in liver and fat leads to 
suppression of the insulin receptor signal by suppressing serine phosphorylation 
of the insulin receptor substrate-1 (IRS-1) (219). XBP-1 deficient mice develop 
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insulin resistance (219). In the hypothalamus of obese mice, increased 
endoplasmic reticulum stress and activation of the unfolded protein response 
inhibits leptin receptor signaling (220). Moreover, chemical chaperones, 4-phenyl 
butyric acid (PBA) and tauroursodeoxycholic acid (TUDCA) improve leptin-
sensitivity (220).  
 
XBP1 β-cell specific knock-out mice display modest hyperglycemia and 
glucose intolerance resulting from decreased insulin secretion from β cells. This is 
due to a decreased number of insulin granules, impaired proinsulin processing, 
blunted glucose-stimulated insulin secretion and inhibited cell proliferation (221). 
A negative feedback activation of IRE1α also contributes to β-cell dysfunction in 
XBP1 mutant mice (221). Meanwhile, XBP1 deficiency in the liver results in 
hypocholesterolemia and hypotriglyceridemia, indicating that hepatic XBP1 is 
responsible for lipogenesis (222). On the contrary, liver IRE1α deletion displays 
modest hepatosteatosis, and was found to be necessary for efficient secretion of 
apolipoproteins upon disruption of ER homeostasis. Furthermore, IRE1α 
represses expression of key metabolic transcriptional regulators including 
CCAAT/enhancer-binding protein (C/EBP)β, C/EBPδ, peroxisome proliferator 
activated receptor γ (PPARγ) and enzymes involved in triglyceride biosynthesis 
(223). 
 
PERK-eIF2α pathway plays an important role in pancreas development. 
Ser51Ala eIF2α mutant mice die after birth with pancreatic β cell deficiency 
(224). PERK is highly expressed in a mouse pancreas, although the exocrine and 
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endocrine pancreas develop normally in PERK -/- mice. Postnatally, IRE1α 
activation and increased cell death lead to progressive diabetes mellitus with 
exocrine pancreatic insufficiency, progressive degeneration of the islets of 
Langerhans and loss of insulin-secreting β cells followed by loss of glucagon-
secreting α cells (225, 226). PERK deficiency causes suppression of insulin 
mRNA and does not lead to uncontrolled protein synthesis (227). Instead it leads 
to impaired ER-to-Golgi anterograde trafficking, retrotranslocation from the ER 
to the cytoplasm, proteasomal degradation, enlarged ER and retention of 
proinsulin (228). Liver specific suppression of eIF2α phosphorylation results in 
lower liver glycogen levels and susceptibility to fasting hypoglycemia in lean 
mice and glucose tolerance and diminished hepatosteatosis (229). Attenuation of 
eIF2α phosphorylation also correlates with the lower lipogenesis transcription 
factor, PPARγ, and its upstream regulators C/EBPα and C/EBPβ (229). Therefore, 
PERK-eIF2α mediates the translation of key hepatic transcriptional regulators of 
glucose and lipid metabolism and thereby contributes to obesity and diabetes. 
 
It is also believed that CHOP is a fundamental factor linking protein 
misfolding in the ER to oxidative stress and apoptosis in β cells under conditions 
of increased insulin demand. CHOP deletion in multiple type 2 diabetes mouse 
models result in improved glycemic control and expanded β cell mass, improved 
β cell ultrastructure and prolonged cell survival (230). In addition, islets from 
CHOP deletion mice show increased expression of UPR and oxidative stress 
response genes and reduced levels of oxidative damage (230). 
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1.5.1.2!ER!stress!and!cardiovascular!diseases!
UPR activation is associated with the pathophysiology of heart failure in 
humans. The hearts showed a marked increase of GRP78 expression and 
morphological change of ER (231, 232). In the mouse model, after transverse 
aortic constriction (TAC), activation of the UPR was found in both hypertrophic 
(1 week after TAC) and failing hearts (4 weeks after TAC). While CHOP was 
activated, JNK or caspase-12 was not, indicating that CHOP may be involved in 
the transition from cardiac hypertrophy to heart failure. ASK1, as previously 
discussed is a kinase to phosphorylate JNK. The ASK1 knock-out mouse model 
also showed fewer cardiac dysfunctions and cardiac apoptosis cells after TAC 
(233). The expression of sarco/endoplasmic reticulum calcium ATPase isoform 3f 
(SERCA3f) was found to be up-regulated in failing human hearts (234).  
 
Moreover, atherosclerosis plaques were found to have ER stress and UPR 
activation in endothelial cells, macrophages and smooth muscle cells (235). In 
normal conditions, macrophages ingest ApoB containing lipoproteins cholesterol 
and the ER esterifies the cholesterol to form cholesterol ester. Excessive amounts 
of free cholesterol, as well as oxysterols induce ER stress and ER stress induced 
apoptosis (110, 236-238). The apoptosis pathway is dependent on CHOP and 
involves the release of ER calcium, the mitochondrial release of apoptogens and 
activation of the death receptor Fas (239-241). For macrophages particularly, the 
ER stress-induced apoptosis usually requires a “second hit” either by pattern 
recognition receptors or by toll-like receptors (242, 243). Oxidized phospholipids 
activate a CD36-TLR2 pathway that initiates an oxidative burst. This oxidative 
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burst further amplifies the CHOP pathway mediated primarily by NADPH 
oxidase (244). Activation of the IRE1α pathway and CHOP was also found in 
smooth muscle cells in the culture treated by 7-ketocholesterol (245), unesterified 
cholesterol (246), homocysteine (247) or glucosamine (248). The mechanism of 
ER stress-induced apoptosis is still not fully understood in smooth muscle cells. 
Apoptotic endothelial cells are procoagulant, and increase the adhesiveness of 
platelets, at least partially, by the mechanism that disturbs blood flow and is 
associated with IRE1-XBP1 branch activation (249, 250). Homocysteine (251, 
252) and modified forms of LDL (253, 254)  are associated with both IRE1 and 
CHOP activation. Activation of IRE1α partially phosphorylates JNK or, by a 
direct interaction with BAX or BAK on the ER membrane, regulates the 
mitochondria dependent apoptosis. On the other hand, PERK or ATF6 activation 
can, in turn, activate Fas signaling pathway to initiate mitochondria independent 
apoptosis, which is mediated by CHOP. Details were discussed previously in 1.3. 
 
Increased expression of UPR-related genes has been reported in 
cardiomyocytes close to the site of myocardial infarction in mice and humans 
(255, 256). Cardiomyocytes infected with a recombinant adnovirus encoding 
dominant-negative XBP1 showed an increased hypoxia/reoxygenation-induced 
apoptosis, suggesting that the XBP1 arm of the UPR may have a cardioprotective 
role against hypoxic insults (255). ATF6 transgenic mice showed increased 
expression of ER resident chaperones GRP78 and GRP94 and better functional 
recovery after ex vivo ischemic/reperfuse (I/R). They also showed significantly 
less necrosis and apoptosis (257). Adenoviral-mediated transfer of the PDI gene 
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also showed significantly reduced cardiomyocyte apoptosis and a smaller left 
ventricular end-diastolic (256). These findings all suggest that activation of the 
UPR plays a protective role against I/R injury. However, with prolonged stimuli, 
ER stress induces the expression of PUMA. PUMA is a pro-apoptotic member of 
the Bcl-2 family. The suppression of PUMA expression leads to inhibition of 
cardiomyocyte apoptosis induced by a pharmacological ER stressor (258). This 
means ER stress can induce both protective UPR and apoptotic signaling in 
ischemic heart diseases, depending on the severity and length of stimuli induced 
by I/R. 
 
1.5.1.3!ER!stress!and!cancer!
Following initiation of malignancy, rapid tumor growth results in 
microenvironmental stress and a change of ER protein homeostasis. Hypoxia, 
glucose deprivation, lactic acidosis, oxidative stress and decreased amino acid 
supplies as well as intrinsic stressors -- such as errors in glycoproteins and lipid 
biosynthesis that result from an increased mutation rate -- all contribute to UPR 
induction (259). Activation of UPR both protects neoplastic cells from apoptosis 
and permits recurrence of tumor growth once favorable growth conditions have 
been restored (260, 261). However, if the stress persists, UPR will promote tumor 
cell apoptosis. 
 
Indeed, ATF6 nuclear translocation has been observed to increase in various 
types of cancers, for example human hepatocellular carcinoma (HCC) (262) and 
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Hodgkin’s lymphoma (263). ATF6 primarily induces cytoprotective responses 
including ER biogenesis, chaperone up-regulation and protein degradation (264, 
265). ATF6 also induces transcription of XBP1 that can adjust the ER capacity to 
match demand. Therefore ATF6 has been hypothesized as a survival factor for 
quiescent carcinoma cells. ATF6 is also responsible for the adaptation of tumor 
cells to chemotherapy which is regulated by the Ras homolog enriched in brain 
(RHEB) and by the mammalian target of rapamycin (mTOR) (266). The ATF6-
RHEB-mTOR pathway could be the possible target for the reduction of the 
metastatic cancer relapse rate (259). 
 
IRE1α has been shown to promote cell proliferation through XBP1, because 
XBP1 splicing itself could lead directly to tumourigenesis. Elevated XBP1s levels 
in B and plasma cells drive multiple myeloma pathogenesis and promote hallmark 
myeloma characteristics (267-269). Moreover, IRE1 is required for tumor 
angiogenesis and also contributes to VEGF expression (270, 271). VEGF can also 
induce internalization of VEGF receptors, and subsequently induce IRE1α 
activation and XBP1 splicing (272). XBP1s also increases BCL-2 levels after 
antiestrogen stimulation in breast cancer cells, and it suppresses apoptosis (273). 
On the other hand, IRE1α prolonged RIDD activation has also been reported to 
induce apoptosis by interacting with TRAF2, which further triggers JNK and 
caspase-12 activation (274, 275). Thus, IRE1α plays a dual role in tumor cell 
survival. 
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Similar to IRE1α, PERK has been implicated in tumor progression and 
angiogenesis. PERK mutation or dominant negative PERK leads to smaller 
tumors and impaired angiogenic abilities (276, 277). PERK knock-down in 
human esophageal and breast carcinomas also results in ROS accumulation, 
oxidative DNA damage and subsequently, cell-cycle arrest at the G2/M phase 
through the PERK downstream transcription factor NRF2 (278, 279). On the 
contrary, pharmacologically activated PERK can also induce growth arrest and 
suppress tumor growth because eIF2α phosphorylation-induced translational 
arrest down-regulates cell-cycle regulators and arrests the cells in the G1 phase 
(280). After acute ER stress, eIF2α phosphorylation stalls protein synthesis to 
reduce the stress. However, if the stress persists, severe ER stress eventually leads 
to ROS and ultimately apoptosis. 
 
ER stress activates UPR in an overlapping mechanism. CHOP is a 
downstream target of all PERK, IRE1α and, to a milder degree, ATF6, although 
PERK-CHOP branch shows stronger activity during prolonged ER stress (281). 
Most targets can be regulated separately by each pathway, while each pathway 
activates its own specific down stream transcriptional activities. Some targets 
require the concomitant activation of two initiators, e.g. P58IPK depends on both 
ATF6 and IRE1α activation (264). Finally, some downstream effectors exhibit 
multiple mechanisms in reducing ER stress. The three UPR pathways can also 
shift balance between cytoprotection and apoptosis based on the timing of ER 
stress. For example IRE1α and PERK initially attenuate ER stress. However, 
sustained PERK activation upregulates CHOP levels, and accumulation of CHOP 
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until it reaches a sufficient level will stimulate the pro-apoptotic BCL-2 family 
proteins. Currently, the way tumor cells adapt to long-term ER stress is unclear, 
and tissue-specific UPR activation also complicates the research. Due to the 
incomplete understanding of UPR pathway redundancy, the timing effect, and the 
interplay between all the UPR pathways, understanding the mechanisms of UPR 
in cancers remains a challenge (259). 
 
1.5.2 ER STRESS AND IMMUNE DISEASES 
The UPR can initiate inflammation in variable cells and tissues. The 
fundamental link between UPR and inflammation is now thought to be an 
important aspect of the pathogensis of inflammatory diseases. The interconnection 
mechanisms include the production of reactive oxygen species (ROS), the release 
of calcium from the ER, the activation of the transcription factor nuclear factor-
κB (NF-κB), JNK, and the induction of the acute-phase response (282).  
 
The process of disulfide-bond formation requires a robust driving force based 
on molecular oxygen because the terminal electron recipient leads to the 
production of ROS (283). Furthermore, additional oxidative stress can result from 
the depletion of reduced glutathione, which is consumed to reduce unstable and 
improperly formed disulfide bonds (284). PERK activates its downstream ATF4 
and phosphorylates nuclear factor-erythroid-derived 2-related factor 2 (NRF2). 
Following phosphorylation, NRF2 translocates to the nucleus, and activates a set 
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of antioxidant plus oxidant-detoxfying enzymes in order to maintain the cellular 
level of glutathionen as a redox buffer in the cell.  
 
As discussed in 1.3.1, IRE1α activation induces a conformational change so 
that its cytosolic domain binds to the adaptor protein tumor-necrosis factor α 
receptor-associated factor (TRAF2) (285). IRE1α-TRAF2 complex recruits IκB 
kinase (IKK), and IKK phosphorylates IκB, which exposes a nuclear-localization 
signal in NF-κB (286). NF-κB is a transcriptional factor that is responsible for 
numerous inflammatory genes. Similarly, IRE1α-TRAF2 complex recruits the 
protein kinase JNK, which activates JNK. JNK induces inflammatory genes by 
phosphorylating the transcription factor activator protein 1 (AP1) (287). PERK-
eIF2α also contributes to the activation of NFκB, because global translation 
attenuation causes a faster degradation of IκB to NFκB due to a shorter half-life 
(288). 
 
UPR participates in the development of autoimmunity. Inadequate UPR and 
aberrant protein folding contribute to autoimmunity through the following four 
mechanisms (289): 1) misfolded proteins overwhelm the UPR and act as 
autoantigenes that promote autoimmunity; 2) UPR-related genes themselves act 
as autoantigens, and it has been suggested that patients with rheumatoid arthritis 
present BIP specific autoantibodies; 3) Defective UPR pathways in non-immune 
cells may still allow autoimmunity by overwhelming normal mechanisms of 
immune tolerance; 4) upregulating ERAD confers resistance to UPR-mediated 
apoptosis or a survival advantage to autoreactive cells. 
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UPR plays an important role in B-cell development and lymphopoiesis, since 
XBP1 is responsible for terminally differentiated immunoglobulin secretions 
during the development of plasma cells (72, 290). Rag (recombinantion activating 
gene-2 RAG2 bloastocyst complementation system) was used to study the role of 
XBP1 in B cells. XBP1-deficient B cells expressed normal cellular markers of 
B220, IgM and IgD. However, Xbp1-/- Rag-/- chimeric mice had decreased basal 
levels of all immunoglobulin isotypes, and failed to produce antibodies in 
response to antigens or viral infection. They also did not express CD138 marker 
for plasma cells, and showed a lack of plasma cell development (72). It is 
believed that the phenotype of Xbp1-/- Rag-/- mice was due to a lack of UPR in 
these B cells (290, 291). The upstream transcription factor B-lymphocyte-induced 
maturation protein 1 (BLIMP1) is also upregulated in XBP1 deficient B cells as a 
lack of negative feedback (291). Interestingly, IRE1α -/- B cells showed similar 
phenotype as Xbp1-/- Rag-/- mice, because the B cells have defects in antibody 
production (292). ATF6 cleavage is also found in stimulated B cells, indicating its 
function in terminal B cell differentiation (293). Yet, PERK-/- B cells develop 
normally into plasma cells (292, 294). The malignant transformation of plasma 
cells form myeloma. Early experiments also showed that Xbp1 was highly 
expressed in myeloma cells (295), and patients with myeloma have high Xbp1s 
levels in the bone marrow (269). Bortezomib, a therapeutic agent for the treatment 
of myeloma, has a potent and selective inhibiting effect on 26S proteasome. 
Therefore the mechanism of selectivity for myeloma cells can be explained by an 
increased susceptibility of myeloma cells to endoplasmic reticulum induced 
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apoptosis; for example, activation of PERK, CHOP and ATF6, as well as JNK 
(296, 297). 
 
In macrophages, TLR2/4 specifically activates the IRE1α-XBP1 pathway and 
activates transcription profiles similar to those under ER stress induction, and 
TLR2/4 is required for optimal expression of cytokines including IL-6, IL-1β, 
TNF and IFN-β (298-300). XBP1 is also essential for dendritic cell (DCs) 
development and survival. Lymphoid chimeras lacking XBP-1 possessed 
decreased numbers of DCs, whereas overexpression of XBP1 rescues and 
enhances DC development (301). On the other hand, prior engagement of TLR3/4 
suppresses CHOP and ATF4 expression in splenic macrophages, renal tubule 
cells, and hepatocytes. Suppression of CHOP and ATF4 prevent renal dysfunction 
and hepatosteatosis, the effect of which is dependent on TRIF. These mechanisms 
might be beneficial for TLR-expressing cells to survive when experiencing 
prolonged levels of ER stress in the process of inflammatory reactions (302). 
 
It has now been reported that ER stress plays a role in inflammatory bowel 
diseases (IBD). XBP1 specific knock-out in intestinal epithelial cells showed 
susceptibility to colitis induced by dextran sodium sulfate and resulted in 
apoptosis of Paneth cells (303). Furthermore, XBP1 deletion in gut epithelia also 
results in the reduction in size and number of goblet cells. In addition, 
autophagosome formation is activated in hypomorphic Paneth cells via PERK, 
eIF2α and ATF4 (304). Commensal microbiota and increased intestinal epithelial 
cell death induce ileitis, and activate the IRE1-NFκB pathway when autophagy is 
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deficient. ATG16L1 is shown to ameliorate ER stress induced intestinal 
inflammation and eases the NF-κB pathway (304). Similarly, dextran sodium 
sulfate (DSS) induced colitis was found in gastrointestinal IRE1β knock-out mice. 
Therefore, a tight regulation of UPR and inflammatory pathways regulate the 
development of inflammatory diseases including inflammatory bowel diseases. 
 
1.6 RESEARCH AIM AND DISSERTATION ORGANIZATION 
Since the identification of UPR sensors in the early 1990s, it has been 
concluded that UPR plays an essential role in maintaining ER protein 
homeostasis. Activation of UPR is known to be required in important 
physiological and pathological regulations. IRE1α-XBP1 is the most famous 
pathway required for plasma cell development and production of 
immunoglobulins and cytokines. Altering the IRE1α signaling pathway is also 
known to affect the severity of diseases including obesity and diabetes, cancer, 
inflammatory diseases and neurodegenerative diseases. In this thesis, chapter 1 
reviewed facts about UPR and ERAD and their relationship to metabolic and 
inflammatory diseases. 
 
Pursuant to this research, the IRE1α-XBP1 pathway is the most 
revolutionarily conserved and well-studied UPR pathway. A comprehensive 
understanding of the regulatory mechanisms underlying mammalian IRE1α 
activation is critical to understanding the UPR and future interventions. Kinase 
activity and trans-autophosphorylation of IRE1α protein are important for the 
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activation of the RNase domain. Moreover, the two cytosolic domains of IRE1α 
protein are functionally linked via autophosphorylation. One outstanding question 
remains: How is the activation of IRE1α RNase and kinase domain coherently 
regulated? And, is phosphorylation of IRE1α dispensable in the activation of its 
RNase domain? Chapter 2 discusses the molecular mechanism of human IRE1α 
activation, and in particular, reveals that the internal link between the kinase and 
RNase domain is required for the coordinated activation of IRE1α and foci 
formation. In appendix A, the importance and mechanism of IRE1α 
phosphorylation based on more mutant variables will be discussed.  
 
Growing evidence has further suggested a close interaction between UPR and 
inflammatory responses. In response to ER stress, IRE1α-TRAF2-JNK pathway is 
activated, as well as NF-κB and CREBH transcription factors that promote pro-
inflammatory responses and acute-phase responses. On the other hand, ER stress 
can also be triggered by inflammation. TNFα causes the activation of all three 
UPR mammalian pathways in fibrosarcoma cells (305). TNFα, IL-1β and IL-6 
also induce UPR activation in hepatocytes (306). ER stress can also be triggered 
by excess metabolic factors such as lipids, glucose, cytokines, and 
neurotransmitters. These stimuli activate UPR, and UPR further causes more 
inflammatory responses and disruption of metabolic functions. Such a cycle 
exacerbates inflammatory signaling and stress signaling and deteriorates 
metabolic phenotypes. 
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Equally important as UPR, ERAD degrades unfolded and misfolded proteins 
from the ER lumen in the cytosolic proteasome and acts upon UPR. Defects in 
ERAD are known to cause accumulation of misfolded proteins or early 
degradation of physiologically required proteins. However, the molecular 
mechanisms of variable mammalian ERAD components remain largely 
unexplored. More research is needed to understand the diversity of E3 ligases, 
their physiological functions in each tissue type and their relevant temporal 
expressing manners. An intriguing question is whether ERAD contributes to 
inflammatory responses. In chapter 3, a macrophage specific Sel1L deletion 
model is used to study the interconnection between ERAD and inflammatory 
responses. Surprisingly, the study shows that Sel1L is dispensable in macrophage 
innate immunity functions. With a lack of Sel1L, macrophages remain intact in 
the functions of cytokine secretion, antigen presenting, pathogen defense and 
inflammatory responses in type 2 diabetes. This research challenges the notion of 
a dependence of UPR in inflammatory responses in highly secretory cell types. It 
also suggests a tightly regulated mammalian ERAD compensatory mechanism. 
 
Finally, chapter 4 summarizes the research findings and discusses the 
direction of future research. 
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2.1 ABSTRACT 
The UPR sensor inositol-requiring enzyme 1α (IRE1α) is a bifunctional 
enzyme containing both kinase and RNase domains that are important for trans-
autophosphorylation and Xbp1 mRNA splicing, respectively, in response to ER 
stress. However, the amino acid residues important for structural integrity remain 
largely unknown.  Here, through analysis of IRE1α mutants associated with 
human somatic cancers, we have identified a highly conserved proline residue at 
position 830 (P830) that is critical for its structural integrity, hence the activation 
of both kinase and RNase domains. Structural analysis revealed that P830 may 
form a highly conserved structural linker with adjacent tryptophan and tyrosine 
residues at positions 833 and 945 (W833 and Y945), thereby bridging the kinase 
and RNase domains. Indeed, mutation of P830 to leucine (P830L) completely 
abolished the kinase and RNase activities, significantly decreased protein stability 
and prevented oligomerization of IRE1α upon ER stress; similar observations 
were made for mutations of W833 to alanine (W833A) and to a lesser extent for 
Y945A. Our finding may facilitate the identification of small molecules to 
specifically compromise IRE1α function. 
 
2.2 INTRODUCTION 
The unfolded protein response (UPR), a highly evolutionarily conserved 
endoplasmic reticulum (ER)-to-nucleus signaling pathway, is critical for 
maintaining ER homeostasis and has been implicated in the pathogenesis and 
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development of many human diseases including diabetes, cancer, and lung and 
heart diseases. UPR, the quality-control system designed to re-establish ER 
homeostasis, is initiated by the activation of three major sensors at the ER 
membrane: inositol-requiring enzyme 1 (IRE1), PKR-like-ER kinase (PERK), and 
activating transcription factor 6 (ATF6). Activation of UPR leads to the induction 
of chaperones and ERAD (ER-associated degradation) components, global 
translational attenuation, and is required for the maintenance of ER function, 
clearance of misfolded protein in the ER, and, if stress persists, induction of 
apoptosis (131). Among the three branches, the IRE1α-initiated pathway is the 
most evolutionarily conserved and represents the only UPR branch in yeast (307, 
308). Recent studies have shown that the IRE1 branch plays important roles in a 
wide range of physiological and disease conditions including B cell and adipocyte 
differentiation, secretory function for pancreas and salivary glands, 
neurodegeneration, and obesity and insulin resistance (131, 309). Hence, a 
comprehensive understanding of the regulatory mechanisms underlying 
mammalian IRE1α activation is critical to the development of new therapeutic 
approaches. 
 
In addition to a kinase domain, the cytoplasmic tail of the IRE1 protein also 
possessed endoribonuclease (RNase) activity, which cleaves Hac1/Xbp1 mRNA 
(310, 311). The Hac1/Xbp1 mRNA encodes for a potent transcription factor 
responsible for the upregulation of many genes involved in protein folding, 
degradation and trafficking (68, 312-314). The ER luminal domain of IRE1α 
protein is critical for sensing ER stress and subsequent IRE1α activation. While 
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earlier studies of human IRE1α have suggested that IRE1α dimers are sufficient 
for its activity (102, 315-317), recent studies showed that the formation of stress-
induced IRE1α foci is conserved between yeast and mammals (104, 105).  The 
formation of IRE1α foci in response to ER stress is believed to juxtapose the 
IRE1α kinase and RNase domains, allowing for a more efficient way to relay 
signals emanating from the ER lumen.  
 
One outstanding question remains as how important is the molecular 
mechanism underlying the activation of IRE1α RNase and kinase domains. Some 
recent studies have shed light on this question. First, kinase-defective K599A 
mutant abolishes the RNase activity of IRE1α, suggesting that kinase activity and 
trans-autophosphorylation of IRE1α protein is important for the activation of its 
RNase domain (104). This is likely achieved by phosphorylation-induced 
conformational changes. Moreover, a previous study reported the failure to 
express stable forms of individual kinase and RNase domains (318). Together, 
these studies imply that the two cytosolic domains of IRE1α protein are 
functionally linked via autophosphorylation. However, two recent studies 
suggested a dispensable role of phosphorylation of IRE1α in activation of its 
RNase domain (319, 320). Thus, further studies are required to elucidate the 
relationship between the two domains.  
 
Through analysis of IRE1α mutants associated with human somatic cancers 
(321), our study identifies the interdomain linker region of the cytosolic domain 
of IRE1α as an important structural determinant for its function. Thus, this region 
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may be used as a potential drug target for small molecules to regulate IRE1α/UPR 
signaling. 
 
2.3 EXPERIMENTAL PROCEDURES 
Cell lines and reagents.  IRE1α-/- MEFs were generous gifts from Dr. David 
Ron (New York University School of Medicine). T-REx293 cell line and T-
Rex293 stably expressing IRE1α-3F6HGFP were recently described (105, 322) 
and provided Dr. P. Walter and Han Li (University of California, San Francisco). 
HEK293T, T-REx293 and Phoenix cells as described (322) were maintained in 
DMEM supplemented with 10% FBS (Hyclone) and 1% penicillin/streptomycin. 
Thapsigargin (Tg) (EMD Calbiochem) and stock cycloheximide (Sigma) were 
dissolved in DMSO and ethanol, respectively.  Cells were treated with Tg at 
indicated concentrations for the indicated times and immediately snap-frozen in 
liquid nitrogen.  Phos-tag was purchased from the NARD Institute (Japan). 
 
Plasmids and mutagenesis. The pDsRed2-ER (Clontech) plasmid was 
provided by Dr. Fenghua Hu (Cornell University). pMSCV-IRE1α–HA encoding 
wildtype human IRE1α (89) was a gift from Dr. C. Hetz (University of Chil). 
IRE1α-3F6HGFP plasmid (105) was provided by Dr. P. Walter and Han Li 
(University of California, San Francisco). Mutagenesis was performed and 
sequenced as described (323).   
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Transfection, retroviral transduction and stable cell lines. HEK293T were 
transfected with plasmids using polyethylenimine (PEI, Sigma) as we recently 
described (323).  Cells were snap-frozen in liquid nitrogen 24 h post-transfection 
followed by Western blot.  To avoid experimental variations due to transfection 
efficiency, stable IRE1α-/- MEF lines expressing various IRE1α constructs were 
generated using retroviral transduction as described (322).  Stable cell lines were 
selected in hygromycin (VWR) at 125 µg/ml. Stable cell lines were made and 
tested independently at least twice.  
 
Analysis of IRE1α foci formation.  It was performed essentially as described 
(105) with the following modifications. T-REx293 cells were transfected with 
0.2-0.5 µg IRE1α-3F6HGFP plasmid and 1 µg OG44 (Invitrogen) for 24 hours 
followed by 62.5 µg/ml hygromycin (VWR) selection for 2-3 weeks.  Cells were 
treated with doxycycline (VWR) at 10nM for 24 h to induce the expression of 
IRE1-3F6HGFP followed by Western blot. Cells were treated with thapsigargin 
(Tg) at 300 nM for 4 hours to induce ER stress. Fluorescent microscopic picture 
of the T-REx293 were taken with the Zeiss 710 confocal microscope. 
 
Intracellular localization of WT and mutant IRE1α with ER marker. T-
REx293 cells stably expressing WT or mutant IRE1α-3F6HGFP were placed on 
the cover slip and grow until 50% confluent. pDsRed2-ER was transfected 1.5 µg 
per well for 6-well for 12 hours followed by 10 nM Dox treatment for 24 hr. 
Fixed by 4% paraformaldehyde for 20 min, washed by PBS twice and d-water 
once, cover slip was then put onto glass slide and stained by prolong Gold 
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antifade reagent with DAPI (invitrogen) and later concealed for observation under 
confocal microscope.  
 
Western blot, phosphatase treatment and image quantification.  
Preparation of cell lysates, nuclear extract, and Western blot were performed as 
we previously described (322, 323). Antibodies used in this study included XBP1 
and HSP90 (Santa Cruz), IRE1α (Cell Signaling) and PARP (a gift from Lee 
Kraus, UT Southwestern Medical Center).  Phos-tag gel and phosphatase 
treatment were performed as described (322, 324, 325). Membranes were 
routinely strip-reprobed for HSP90 as a position control.  Band density was 
quantitated using the Image Lab software on the ChemiDOC XRS+ system (Bio-
Rad) and presented as mean ± SEM from several independent experiments or as 
representative data from at least two independent experiments.  
 
RNA extraction and XBP1 splicing assay. RNA extraction was 
described in the previous paper (322). XBP1 splicing assay was performed 
following David Ron’s protocol at 
http://saturn.med.nyu.edu/research/mp/ronlab/protocols.html. 
 
Structure of yeast and human IRE1α.  The crystal structure of the cytosolic 
domain of yeast IRE1α (PDB accession number 3FBV) (104) and human IRE1α 
(PDB accession number 3P23) (103) were used for structural analysis of IRE1α 
mutants. 
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Cycloheximide treatment.  Stable MEF cell lines with various IRE1α 
constructs were treated with 100µg/ml cycloheximide  (Calbiochem) for 0, 6, 9, 
12, 16 and 24 hours. Cells were then snap-frozen in liquid nitrogen and analyzed 
by Western blot and image quantification. 
 
Statistical analysis.  Results are expressed as mean ± SEM. Comparisons 
between groups were made by unpaired two-tailed Student t-test.  P<0.05 was 
considered as statistically significant. All experiments were repeated 
independently at least twice. 
 
2.4 RESULTS 
The S769F and P830L mutations abolish IRE1α phosphorylation and 
activation. In a recent proteomic screening study, seven mutations (N244S, 
L474R, R635W, S769F, Q780-stop and P830L) were identified to be associated 
with various cancers (321) (Figure 2.1A).  As they present in tumor cells in one 
copy (321), their significance in cancer is unclear. Nonetheless, the identification 
of these mutants allowed us to address how the cancer-associated mutation may 
affect IRE1α structure and function. The relative positions of these mutations in 
the kinase domain of the active form of yeast IRE1α protein (104), based on 
homology, are shown in Figure 2.1B.  
 
 To determine the impact of these mutants on IRE1α activity, we generated 
IRE1α-/- MEF cells stably expressing the mutant proteins and assessed IRE1α 
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phosphorylation in response to ER stress using Phos-tag gels as we recently 
described (322, 324, 325).  Our previous studies have shown that the slower-
migrating band on the Phos-tag gel represents the phosphorylated form of IRE1α 
and the ratio of phosphorylated- to total- IRE1α correlates with the amount of ER 
stress (324, 325). Strikingly, mutation of IRE1α at either S769F or P830L, but not 
R635W nor L474R, completely abolished IRE1α mobility shift upon thapsigargin 
(Tg) treatment, indicating defective IRE1α kinase activity (lanes 7-14 of Figure 
2.2A and lanes 1-8 of Figure 2.2B).  Of note, we were not able to detect N244S 
and Q780stop mutant proteins due to technical reasons.
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A
Tissue Histology/type cDNA annotation AA annotation Location
Renal Clear cell carcinoma A731G N244S ER lumen
Lung Adenocarcinoma T1421G L474R Cytosol (linker)
Stomach Adenocarcinoma C1903T R635W Cytosol (Kinase)
Brain Glioblastoma C2306T S769F Cytosol (Kinase)
Brain Glioblastoma C2338T Q780* (STOP) Cytosol (Kinase)
Ovary Serous carcinoma C2489T P830L Cytosol (Kinase)
571 832
835 963
TM
444 464
1
*
N244S
*
L474R
*
R635W
*
S769F
*
Q780*
*
P830L
RNase
Kinase
LinkerLuminal
human IRE1α
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Figure 2.1 The P830L mutation identified in human cancers abolished IRE1α 
phosphorylation and activation.   
The list of mutations identified in human cancers (upper) and their distribution in 
human IRE1α (lower). Mutations that abolish IRE1α activity are highlighted in 
red. Luminal, luminal domain; TM, transmembrane; Kinase, kinase domain and 
RNase, RNase domain of human IRE1α.  (B) Location of four mutations in the 
kinase domain of yeast IRE1α protein.  Kinase domain in orange, RNase domain 
in green and activation loop in blue shown. The amino acid position in yeast, 
based on homology, indicated.  Position in human IRE1α protein indicated in 
parenthesis.
B
P978 (P830)
S915 
(S769)
S926 
(Q780)
R739 
(R635)
RNase
Kinase
activation 
loop
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 It is worth pointing out that it is necessary to use phos-tag gels to analyze 
phosphorylation of IRE1α mutants, as p-IRE1α did not separate well in regular 
gels under the same running conditions (Figure 2.2B-C). The kinase-dead K599A 
mutant (326) exhibited no IRE1α phosphorylation while dimerization-defective 
D123P mutant (317) showed a 70% reduction (lanes 7-8 and 10-11, Figure 2.2C). 
As additional controls, mutations at S548D and T973D had no effect on IRE1α 
phosphorylation upon ER stress (lanes 1-6, Figure 2.2A). Supporting the notion 
that the slower migrating band is due to phosphorylation, phosphatase treatment 
abolished the band shift in WT IRE1α (lane 3, Figure 2.2C); by contrast, there 
was no change in the electrophoretic mobility of P830L IRE1α following 
phosphatase treatment (lanes 4-6, Figure 2.2C). Quantifications of the percent of 
p-IRE1α in total IRE1α from at least two independent experiments are shown in 
Figure 2.2D and E. 
 
 To further examine the effect on RNase activity, we assessed the 
production of XBP1s protein by Western blot.  K599A completely and D123P 
partially abolished XBP1s production (lanes 5-8, Figure 2.2F lower) while other 
mutations such as K748A and T973D (lanes 9-12, Figure 2.2F lower) had no 
effect. XBP1s protein was barely detectable in IRE1α-/- MEFs expressing P830L 
or S769F (lanes 9-12, Figure 2.2F upper), but was less affected in cells expressing 
L474R or R635W (lanes 5-8, Figure 2.2F upper). This was also confirmed by RT-
PCR analysis of Xbp1 mRNA splicing (lanes 5-6, Figure S2.1).  Taken together, 
among the 4 cancer-associated mutants, our data showed that P830L and S769F 
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mutations had detrimental effect on IRE1α kinase and RNase functions whereas 
L474R and R635W had no major impact. 
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Figure 2.2 The P830L mutation abolished IRE1α phosphorylation and activation. 
(A-C) Western blot analysis of IRE1α in cell lysates of IRE1α-/- MEFs stably 
expressing wildtype or mutant IRE1α. Cells were treated with 60nM Tg for 3 hr. 
In C, lysates were treated with λPPase. Phos-tag gels indicated with a straight line 
on the left-hand side. HSP90, a loading control. Note the difference of IRE1α 
pattern in Phos-tag gels vs. regular SDS-PAGE gels. (D-E) Quantitation of p-
IRE1α in Phos-tag gels shown in panels A-C. Results expressed as mean ± SEM. 
All the P values <0.05 using unpaired Student’s t-test comparing the P830L to 
other mutants or wildtype (except S769F and K599A). For simplicity, the P 
values are not indicated in the figures. (F) Western blot analysis of XBP1s protein 
in IRE1α-/- MEFs stably expressing wildtype or mutant IRE1α. Cells were treated 
with 60 nM Tg for 3 hr. *, a non-specific band. Data is representative of at least 
two repeats with two independent stable cell lines for each mutant. 
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P830 is located in a linker region bridging two domains of IRE1 protein.  
We then analyzed potential effect of the two loss-of-function mutants on IRE1α 
structure (Figure 2.3A). Based on the structure of human IRE1α (103), S769 is 
located in the kinase domain (Figure 2.3A). Replacement of the serine with a 
bulky phenylalanine residue causes sterical collisions with at least two 
neighboring residues Y765 and C794 (Figure 2.3B), which may affect the 
stability and activation of the kinase domain. While C794 is not conserved, both 
S769 and Y765 are highly evolutionally conserved (Figure 2.3D).   
 
 Interestingly, P830 is located at the junction between the kinase and 
RNase domains (Figure 2.3A). Further analysis revealed that P830 may form a 
highly hydrophobic patch with W833 and Y945 or with L941 on the other side 
(Figure 2.3C).  Based on this, mutation of P830 to L was not favored as the side 
chain of leucine (L) would contact the W833 and Y945 residues (Figure 2.3C), or 
L941 in the other direction (not shown), and hence, disrupt this structural element. 
All four residues involved in this structural motif (P830, W833, L941 and Y945) 
were highly conserved in both IRE1α and IRE1β proteins through evolution from 
yeast to humans (Figure 2.3E), suggesting that the P830-containing structural 
linker bridging the two domains of IRE1 may be critical for IRE1 activation in a 
highly conserved manner. We speculated that understanding the effect of P830L 
may provide some insight into the importance of the region linking the kinase and 
RNase domains of IRE1α, hereafter termed the “linker”. Therefore, in the 
remainder of this study, we focused on the P830 residue. 
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Figure 2.3 P830 is located in the highly conserved hydrophobic patch connecting 
two domains of human IRE1 proteins.  
(A) Ribbon diagram of the cytosolic domain of human IRE1α protein (PDB 
accession number 3P23) highlighting two cancer-relevant mutations, the S769F 
(in purple box) and P830L site  (in red box).  (B) A close view of the S769 site in 
wildtype (left) and the structural modeling of the S769F mutant (right). Residues 
(Y765 and C794) that in close contact with the modeled phenylalanine (F) are 
shown in sticks. (C) A close view of the P830 site in wildtype (left) and the 
structural modeling of the P830L mutant (right).  Residues (W833, Y945, and 
L941) that may be in collision with the mutant leucine (L) are shown in sticks. P, 
proline; W, tryptophan; Y, tyrosine; L, leucine; S, serine and C, cystein. (D-E) 
Amino acid sequence alignment showing the conservation of (B) S769, Y765 and 
C794 residues and (E) P830, W833 and Y945 and L941 residues in IRE1 
proteins. Number refers to residue positions in human IRE1α protein. H. Sapiens, 
human; P. troglodytes, chimpanzee; M. mulatta, macaque; E. caballus, horse; M. 
musculus, mouse; G. gallus, chick; O. latipes, fish; D. melanogaster, fly; C. 
elegans, worm; S. cerevisiae, yeast. 
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The structural element consisting of P830-W833-Y945 is critical for 
IRE1α function.  We next attempted to delineate the effect of this hydrophobic 
patch consisting of P830, W833 and Y945 or L941 on IRE1α activation by 
mutagenesis. Interestingly, W833A caused a similar dramatic defect on IRE1α 
phosphorylation as P830L in response to ER stress (lanes 7-8 Figure 2.4A), and to 
a lesser extent for Y945A (lanes 11-12 Figure 2.4A), but not L941A (lanes 9-10, 
Figure 2.4A).  To exclude the possibility that the P830L effect was caused by 
random mutations generated at other sites during mutagenesis, we mutated P830L 
back to P (P830L→P).  Indeed, the P830L→P mutation fully restored the WT 
phenotype (lanes 13-14, Figure 2.4B). Pointing to the importance of the P830 
position, mutation at the nearby P821L, also a highly conserved residue (Figure 
2.3E), had only a minor effect (~20%) on IRE1α phosphorylation (lanes 5-6, 
Figure 2.4B).  Moreover, mutation of P830 to alanine (P830A) caused a much 
milder defect in IRE1α phosphorylation relative to the P830L mutant, with ~70% 
of IRE1α being phosphorylated under ER stress (lanes 1-2, Figure 2.4B-C).  
 
      Next, we asked whether mutating Y945 or W833 to a smaller residue 
alanine could reverse the detrimental effect of P830L by accommodating P830L. 
However, the double mutants of P830L/Y945A or P830L/W833A exhibited the 
same phenotype as P830L with no IRE1α phosphorylation in response to ER 
stress (lanes 7-8 and 11-12, Figure 2.4B). Quantification of IRE1α activation in 
all mutants was shown in Figure 2.4C. Thus, these data suggest that the P830-
W833-Y945 residues, not P830-L941, form a structural linker bridging the two 
cytosolic effector domains of IRE1α.   
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 Next we checked the RNase activity of these mutants by assessing the 
protein levels of XBP1s using Western blot.  Indeed, XBP1s protein levels 
seemed to correlate with the extent of IRE1α phosphorylation: The P830L, 
W833A or Y945A mutations led to no XBP1s production in response to ER 
stress, and to a much lesser extent for L941A and P830A (Figure 2.4D). As a 
positive control, RNase-dead K907A mutant (327) with normal IRE1α 
phosphorylation (lanes 5-6, Figure 2.4A) was defective in XBP1s production in 
response to ER stress (Figure 2.4D). Taken together, our data showed that three 
residues P830, W833 and Y945 likely form a structural linker that is critical for 
IRE1α function. 
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Figure 2.4 The structural element consisting of P830-W833-Y945 is critical for 
IRE1α function.   
(A-B) Western blot analysis of IRE1α in cell lysates of IRE1α-/- MEFs stably 
expressing wildtype or mutant IRE1α. Cells were treated with 60nM Tg for 3 hr. 
(C) Quantitation of p-IRE1α in Phos-tag gels shown in panels A-B. Results 
expressed as mean ± SEM, an average of at least two independent experiments. 
All the P values <0.05 using unpaired Student’s t-test comparing the P830L to 
other mutants or wildtype (except W833A). For simplicity, the P values are not 
indicated in the figures. (D) Western blot of XBP1s protein in IRE1α-/- MEFs 
stably expressing wildtype or mutant IRE1α. Cells were treated with 60nM Tg for 
3 hr. Phos-tag gels indicated with a straight line on the left-hand side of the gel. *, 
a non-specific band.  HSP90, a loading control. Data is representative of at least 
two repeats for each mutant. 
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The P830-containing structural linker of IRE1α is important for its 
stability.  To further shed light on the defects caused by P830L, we examined the 
stability of IRE1α mutants under basal conditions. IRE1α-/- MEFs stably 
expressing various mutant proteins were treated with cycloheximide, an inhibitor 
of protein synthesis, for the indicated time periods followed by Western blot 
analysis of IRE1α protein levels. While K599A had a similar half-life as wild type 
protein (t1/2 = 12 h, Figure 2.5A-B), the P830L, W833A and Y945A mutations 
dramatically reduced the half-life of IRE1α to 6 hours or less (Figure 2.5D-F), 
pointing to the specificity of these three residues, but not L941A on IRE1α 
stability (Figure 2.5C). Taken together, these results suggested that P830L, 
W833A and Y945A mutations at the linker region had a significant impact on 
IRE1α protein stability, an effect distinct from the kinase-dead K599A mutation. 
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Figure 2.5 The P830-containing structural linker of IRE1α is important for its 
stability.  
Western blot analysis of IRE1α (upper) and quantitation of IRE1α half-life 
(lower) for IRE1α-/- MEFs stably expressing wildtype or mutant IRE1α. Cells 
were treated with cycloheximide (CHX) for the indicated time. IRE1α protein 
levels at various time points were normalized to the 0 time point of its own 
protein. Protein half-life refers to the time at which protein levels reach to 50% of 
that at 0 time point. Data is representative of at least two repeats for each mutant. 
HSP90, loading control. 
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The P830-containing structural linker of IRE1α is important for its 
oligomerization.  As mammalian IRE1α oligomerizes upon ER stress (105), we 
next tested the effect of P830L on its foci formation. To this end, we used an 
inducible system to detect IRE1α foci formation in T-REx293 cells (105) (Figure 
2.6A).  Using co-expression of ER-localized dsRed encoded in the pDsRed2-ER 
plasmid, we first confirmed that exogenous wild type and mutant IRE1α proteins 
were predominantly localized to the ER (Figure S2.2).  In line with a previous 
study (105), foci formation peaked in cells expressing WT-IRE1α protein upon 4 
h treatment of 300 nM TG (Figure 2.6B and not shown).  Interestingly, unlike 
wildtype IRE1α protein, P830L IRE1α protein failed to form foci upon ER stress 
(Figure 2.6C), so did the dimerization-defective D123P IRE1α (Figure 2.6D).  
Thus, these results suggested that the P830-containing structural linker of IRE1α 
affects its oligomerization in response to ER stress.  
 
 To test whether mutant IRE1 protein would have a dominant negative 
effect on endogenous IRE1α protein, we transfected mutant proteins into 
HEK293T cells and tested for ER stress response. Despite being 10-fold more 
than endogenous protein, exogenous mutant proteins failed to significantly reduce 
IRE1α activity as assessed by XBP1s protein levels (Figure 2.6E).  This result 
suggested that the P830L mutant does not act as dominant negative mutation, 
rather might just act a loss-of-function mutation.  
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Figure 2.6 The P830-containing structural linker of IRE1α is critical for its 
oligomerization in response to ER stress.  
(A) Western blot of IRE1α-GFP proteins in the T-REx293 system. Parental T-
Rex293 cells (-) or T-REx293 cells stably expressing different IRE1α proteins, 
either WT or D123P or P830L, were treated with 10 nM Dox for 24 hr followed 
by Western blot. (B-D) Confocal microscopic images of IRE1α foci in wildtype 
(B), P830L (C) and D123P (D)-expressing cells treated as in A with or without 
300 nM Tg for 4 hr. Images are representatives of over 100 cells from 3 
independent experiments. Scale bar, 5 µm.  (E) Dominant negative effect of 
P830L. Western blot analysis of XBP1s and IRE1α following overnight 
transfection of HEK293T cells with near 100% transfection efficiency.  Cells 
were treated with 300 nM Tg for 4 hr prior to harvest.  PARP and HSP90, loading 
controls for XBP1s and IRE1α, respectively. Representative of two independent 
experiments.  Numbers shown below the XBP1s blot refer the relative abundance 
of XBP1s protein (after normalized with PARP). Arrow next to the IRE1α blot 
indicates the endogenous IRE1α band.  The ratio of endogenous to exogenous 
IRE1α protein levels is 1:10. 
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SUPPLEMENTARY FIGURES 
 
 
 
 
 
 
 
 
 
Figure S2.1 Xbp1 mRNA splicing.  
RT-PCR analysis of Xbp1 mRNA splicing in IRE1α-/- MEF stably expressing 
various IRE1α mutants.  Cells were treated with 60 nM Tg for 3 hr.  L32, a 
loading control.  Xbp1u and s are shown.  Representative of two experiments. 
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Figure S2.2 Confocal analysis of intracellular localization of IRE1α WT and 
mutants.  
Cells expressing wildtype (top), P830L (middle) and D123P (bottom) IRE1α-
3F6HGFP were co-transfected with ER-dsRed plasmid to mark the ER. No 
observable difference was found for WT or mutant IRE1α location in the ER. 
Images are representatives of over 100 cells from 2 independent experiments.  
Scale bar, 10 µm. 
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2.5 DISCUSSION  
 This is the first study addressing how cancer-associated IRE1α mutations 
affect its structure and function. Here we have identified an important structural 
element that is critical for the function of IRE1α. This structural linker consisted 
of P830, W833 and Y945 bridges the kinase and RNase domains of IRE1α 
protein. Disturbance of this linker structure abolishes the activities of both the 
kinase and RNase domains of IRE1α and prevents foci formation in response to 
ER stress. This mechanism is likely to be evolutionarily conserved as these three 
residues are highly conserved from yeast to humans. Although it remains unclear 
how P830L affect tumor development in vivo (This mutation is probably not 
tumorigenesis because it led to a defect in XBP1s pro-survival signaling.  
However, it is not the focus of this study), this study demonstrates that the P830L 
mutation is deleterious for IRE1α stability and function. 
 
 How the folding and activation of two cytosolic domains of IRE1α are 
coupled in vivo remains unclear. Currently, one prevailing model is that the 
activation of the RNase domain of IRE1α depends on the trans-
autophosphorylation of its adjacent kinase domain following dimerization or 
oligomerization (131, 318).  Efforts to further understand this phosphorylation-
mediated regulatory event is hampered by the fact that specific phosphorylated 
residues on mammalian IRE1α protein remain unknown. In yeast, an estimated 17 
Ser/Thr residues located at both the activation loop and the adjacent αEF-αF loop 
are believed to be phosphorylated under ER stress (104). While we predict that 
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trans-autophosphorylation of mammalian IRE1α protein is not likely to be as 
extensive as in yeast, as indicated in the Phos-tag-based Western blots (322, 324, 
325), the identities and the importance of these possible phosphorylation sites on 
the activation of mammalian IRE1α protein remains an interesting question.  
 
 Our data suggest that the “P830-W833-Y945” residues in the IRE1α 
hydrophobic core are important for its folding and activation. This linker region 
affects not only the activities of the kinase and RNase domains, but also its half-
life and the ER-stress-induced oligomerization. The effect of P830-related 
mutations on IRE1α function is indeed more severe than the kinase-dead K599A 
and dimerization-defective D123P mutants, suggesting that P830-related 
mutations may interfere with the folding process of IRE1α protein.  How we can 
translate this finding to therapeutic purposes require further studies.  
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2.7 APPENDIX 
2.7.1 The P830-containing structural linker of IRE1α is important for cell 
growth.  
 
Introduction 
IRE1α and its down stream XBP1s were previously reported to govern cell 
fate in a cell type specific and condition specific way (74). It was demonstrated 
that XBP1 expression was induced in cancers including multiple myeloma, acute 
myeloid leukemia, and breast cancer (273, 328-332). The role of XBP1 as a 
survival factor in cancer cell types makes it a potential drug target. The initial 
identification of P830L in ovary serous carcinoma (321) raised the crucial 
scientific question: What is the biological consequence of this mutation in cancer 
formation? Soft Agar Assay for colony formation is an anchorage independent 
growth assay, normally considered as the most stringent assay for detecting 
malignancy. Therefore, WT and P830L IRE1α mutant, as well as P830A, K599A, 
L941A and L945A IRE1α mutant MEFs were used to perform soft agar assay.  
 
Experimental Procedures 
Soft Agar Assay 
0.5% base agar (Sigma Agarose, Type VII (A4018-5G)) with 1X Dulbecco’s 
Modified Eagle Medium (DMEM) and 10% fetal bovine serum (FBS) were 
prepared and 1ml was used in a well of a 6-well plate. The plates were stored at 
room temperature for more than 30 minutes to solidify. Top agar 0.3% with 1X 
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DMEM and 10% FBS were than prepared and preheated to 37 °C and mixed with 
5000 cells to cover the top of the base agar. The cells were incubated under 
normal conditions and 1.5ml of regular media were added at the top biweekly. 
The cells were incubated to grow for 3 weeks. Then the number and size of the 
colonies were observed by light microscope (ZEISS SN 3832000516). Whole 
plate pictures were scanned by a printer. 
 
Results 
Compared with IRE1α -/- MEFs transfected with wild type IRE1α, P830L 
IRE1α mutant MEF cells showed a much slower rate of growth. The P830 mutant 
group showed much fewer and smaller colonies; whereas a less severe growth 
retardation was observed in K599A, P830A, L931A and Y945A IRE1α mutant 
MEFs (Figure. Appendix 1.1). This result was consistent with the XBP1s mRNA 
splicing and protein level and indicated that XBP1 plays a pro-survival role in 
MEFs and that the P830 containing linker region is critical for the effective 
cleavage event of XBP1. 
  
  
 
 
 
 
84 
 
A
WT P830L
K599A P830A
L941A Y945A
B
WT P830L K599 P830A Y945AL941Avector
  
 
 
 
 
85 
 
Figure. Appendix.1.1 P830-L941-Y945 linker mutation causes cell growth 
retardation. 
IRE1α -/- MEFs expressing empty vector, WT, P830L, P830A, K599A, 
L941A, and L945A mutant IRE1α were cultured to perform soft agar assay. (A) 
Pictures showed the formation of colonies in the wells of 6-well plates after three 
weeks. (B) Pictures showed the representative morphology and relative size of 
colonies under 10X5 ZEISS microscopy magnification. (C) The chart showed the 
quantification of average colony numbers in each well (n=3).  
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Discussions 
It remains puzzling why IRE1α mutants in cancer were proved to be anti-
malignancy. One possible explanation is that these mutations were not a cause of 
malignant transformation. Instead, the lack of a DNA error correction system (e.g. 
P53) led to a random mutation which coincidentally depleted the IRE1α normal 
function. Another potential explanation was the presence of a negative feedback 
due to increased pro-survival signaling in the cancer cells. However, the 
transcriptional regulation of IRE1α appeared stable; therefore, this possibility was 
less likely. Nevertheless, the biological effect of P830L IRE1α mutant in MEFs 
colony formation assay further proved the role of P830-containing linker in 
activating IRE1α-XBP1 signaling. Currently the idea of developing a drug based 
on this residue seems promising. 
 
In the past, IRE1α has been shown to be a cell fate determinant. The 
downstream of IRE1α, XBP1s, could therefore directly lead to tumorigenesis. 
Relevant evidence indicates that increased XBP1s levels in B cells could drive 
multiple myeloma pathogenesis (269). Evidence also indicates that XBP1s could 
promote cell proliferation by regulating cyclin A1 expression in prostate cancer 
cell lines (267). However, IRE1α can also promote apoptosis by mediating JNK 
pathway (274) or by mediating prolonged RIDD (333). Activation of JNK can 
induce caspase-12 signaling pathway and apoptosis (274). Although the 
mechanisms remain unclear, prolonged RIDD activation also increases apoptosis 
(319). Therefore, it is important for us to understand that the biological effect of 
IRE1α P830L mutant is depleted cell growth signaling. This further proves that 
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the linker region containing P830 can serve as a drug target to suppress cell 
growth in cancers. 
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2.7.2 Analysis of IRE1α phosphorylation sites on the activation loop 
 
Introduction 
Controversy still surrounds the question: Is autophosphorylation of IRE1α 
required for its activation? On one side, abundant evidence shows that in yeast the 
activation of the RNase domain of IRE1α depends on the trans-
autophosphorylation of its adjacent kinase domain. Following a signal, trans-
autophosphorylation of the kinase domain makes the unfettered binding of 
nucleotide possible, which in turn, promotes dimerization or oligomerization to 
compose the ribonuclease activity (131, 318). On the other side, two papers 
suggest a dispensable role of phosphorylation of IRE1α in activation of its RNase 
domain (319, 320). They show that a L745G mutant IRE1α, which has a defect in 
kinase activity and phosphorylation, can constitutively activate all downstream 
functions in the presence of an ATP-competitive inhibitor 1NM-PP1 through 
conformational change in the kinase domain (319, 320).  
 
The effort to further understand this phosphorylation-mediated regulatory 
event on mammalian IRE1α protein is hampered by the fact that specific 
phosphorylated residues remain unknown. In yeast, an estimated 17 Ser/Thr 
residues located at both the activation loop and at the adjacent αEF-αF loop are 
believed to be phosphorylated under ER stress (104). While we predict that trans-
autophosphorylation of mammalian IRE1α protein is not likely to be as extensive 
as in yeast, as indicated in the Phos-tag-based Western blots (322, 324, 325), the 
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identities and the importance of these possible phosphorylation sites on the 
activation of mammalian IRE1α protein still pose interesting questions.  
 
 From all the phosphorylation sites in yeast, we selected evolutionarily 
more conserved Serine (S) sites on the human IRE1α activation loop as 
candidates, S724, S726 and S729. We mutated them either into smaller nonpolar 
amino acid Alanine (A) as a loss of phosphorylation mutation, or mutated them to 
the acidic polar residues Aspartic acid (D) or Glutamic acid (E) to determine if the 
mutations would enhance phosphorylation. The phosphorylation of IRE1α was 
then evaluated in both the basal and ER stress conditions by phos-tag gels. 
Downstream effectors XBP1 splicing and XBP1s protein levels were evaluated to 
understand their relevant RNase activity. 
  
Experimental Procedures 
As described in chapter 2.3, alignment structure pictures were produced by 
PyMOL. 
 
Results 
S724 and S726 are two phosphorylation residues of human IRE1α. 
Stable cell lines were produced by using IRE1α -/- MEFs cells expressing 
mutant human IRE1α plasmids following mutagenesis. By aligning seven species’ 
IRE1α activation loops, two Serine (S) residues were found to be the most 
conserved -- S724 and S726 (Figure. Appendix 2.1 A upper). Structural pictures 
also showed that human IRE1α S724 matched S841 in yeast, while S726 has a 
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different spacial position than S726 in yeast (Figure. Appendix 2.1 A lower). This 
indicates the phosphorylation status of mammalian IRE1α might be differently 
regulated than that in yeast. Very interestingly, we found that S724A and S726A 
mutant cell lines both showed an almost complete abolishion of IRE1α 
phosphorylation (Figure. Appendix 2.1 B) in the ER stress condition. The down 
stream effect of IRE1α activation such as XBP1 splicing and chaperone induction 
(Figure. Appendix 2.1 C), as well as the XBP1s protein level (Figure. Appendix 
2.1 B) were consistent with the phosphorylation level. Therefore, we concluded 
that for human IRE1α, phosphorylation is important for its kinase and RNase 
domain activation. S724 and S726 are two phosphorylation sites of human 
hIRE1α. 
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Figure. Appendix.2.1 S724 and S726 are two phosphorylation residues of human 
IRE1α. 
(A) Alignment of IRE1α activation loop. The lower part shows the alignment 
of the activation loop between yeast (orange) and human (blue) IRE1α in a 3D 
structure. (B) IRE1α -/- MEFs expressing WT, S724A and S726A IRE1α 
plasmids treated with or without Tg in a time course. Hsp90 is the loading control 
for cytosolic fraction and Lamin A/C is the loading control for nuclear fraction 
XBP1s. Phostag gels show the phosphorylated and non-phosphorylated IRE1α. 
(C) qPCR data showing the induction of UPR genes in three cell line groups in a 
Tg treatment time course. 
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When mutating the S724 and S726 to the acidic polar residues Aspartic 
acid (D) or Glutamic acid (E), S726D and S726E showed similar 100% 
phosphorylation under ER stress conditions, while at basal level, they do not 
exceed the phosphorylation level of WT (Figure. Appendix 2.2 B, data not 
shown). S726D IRE1α also can induce full activation of XBP1s as WT (Figure. 
Appendix 2.2 A). S724D was found to be similar to S726D in its downstream 
effect shown as full XBP1s expression (Figure. Appendix 2.2 A). However, 
S724D appeared not to be fully phosphorylated upon ER stress. The 
phosphorylation condition of S724D was difficult to interpret because the 
phosphorylation band seemed to migrate more slowly than the non-
phosphorylated band but faster than the fully phosphorylated bands of WT and 
S726D. It is not yet known whether there is a half-phosphorylated condition. 
(Figure. Appendix 2.2 B). This means that although S724 is a very important 
residue for IRE1α phosphorylation and its RNase function, under certain 
conditions such as S724D mutation, phosphorylation can still be bypassed to 
permit XBP1s full expression. Non-conserved nearby residue S710 showed no 
defect in phosphorylation under ER stress. The less conserved residue S729 
showed a half reduction in phosphorylation and XBP1s production compared to 
WT (Figure. Appendix 2.2 A,B). Kinase dead IRE1α mutant K599A (326) and 
luminal domain mutant D123P (182) were used as controls (Figure. Appendix 2.2 
C). PERK phosphorylation conditions were not affected by IRE1α mutants 
(Figure. Appendix 2.2 B).  
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Figure. Appendix.2.2 S726D IRE1α mutant shows full phosphorylation ability  
IRE1α -/- MEFs expressing mutant IRE1α plasmids, as indicated in the above 
figure, were treated with or without Tg. (A) (D) XBP1s protein level of IRE1α 
mutants were shown in western blots. (B) (C) IRE1α phosphorylation and PERK 
phosphorylation under the condition of various IRE1α mutants were shown in 
western blots. Hsp90 is the loading control for cytosolic fraction (IRE1α and 
PERK). Lamin A/C is the loading control for nuclear fraction. 
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Based on the previous discovery that S724, S726, and S729 to a lesser 
extent, are responsible for mammalian IRE1α phosphorylation, we next wanted to 
know what are the possible residues interacting with these serine residues. Thus, 
we aligned human and yeast IRE1α in a 3-D structure using the yeast 
oligomerization model (104). It was found that D575 in humans and K678 in 
yeast could be related to S724 and S841 in human and yeast IRE1α, respectively 
(Figure. Appendix 2.3). K574 might be related to S726 (Figure. Appendix 2.3).  
  
  
 
 
 
 
97 
 
 
Figure. Appendix.2.3 Alignment of yeast and human IRE1α two monomers in an 
oligomerization model. 
Alignment of yeast (orange and yellow) and human (blue and green) IRE1α in 
a 3D structure shows two monomers of IRE1α in the oligomerization model. In 
the corner, magnified activation loops are shown and possible interaction between 
residues is indicated. 
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Based on the phenotype of a full phosphorylation ability of S726D, we 
made a double mutant S726D/K574A. Indeed, this double mutant showed 
abolishion of phosphorylation under ER stress condition but K574 single mutant 
cells were not affected. This proved that K574 residue contributes to S726 
phosphoryation; therefore possible residue interactions are likely to exist (Figure. 
Appendix 2.4 A, B). Similarly D575K mutant cell lines showed normal 
phorsphorylation in ER stress. However, trying to rescue the phosphorylation 
defect in S724D mutant by changing the D575 to a positively charged residue 
lysine (K) failed to show any improvement (Figure. Appendix 2.4 C, D). 
Therefore, there is no conclusive association between D575 and S724. Further 
study is required to assess the exact conformational change based on S724D 
mutation. It is also puzzling that, even with a defect in IRE1α phosphorylation, 
double mutant S726D/K574A and S724D/D575K both lead to only a slight 
reduction in XBP1s expression (Figure. Appendix 2.2 D). S724D/S726D and 
S726D/S729D have reduced XBP1s; S724A/S726A and S726A/S729A have no 
XBP1s expression (Figure. Appendix 2.2 D). 
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Figure. Appendix.2.4 Possible interaction between S726 and K574 in hIRE1α 
(A) (C) IRE1α -/- MEFs expressing mutant IRE1α plasmids as indicated in the 
figure were treated with or without Tg. Hsp90 is the loading control for cytosolic 
fraction. Phos-tag gels show the phosphorylated and non-phosphorylated IRE1α. 
(B) (D) 3D structural alignment shows a special relationship between the residues 
indicated. 
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Discussion 
This appendix shows the importance of phosphorylation in human IRE1α 
activation. It has been proved that by mutating S724 or S726 to alanine causes a 
defect in IRE1α downstream functions including XBP1 splicing. However, it still 
cannot be concluded that phosphorylation of IRE1α is absolutely required for its 
RNase function. Because situations were observed, such as S724D and 
S726D/K574A mutants, which does not present a full phosphorylation phenotype, 
still possessing almost normal XBP1s protein levels. Yet, in most situations, 
IRE1α phosphorylation condition still correlates with the extent of XBP1 splicing. 
Therefore, the phos-tag gel measuring the percentage of IRE1α is still a valuable 
tool to understand the activation status of human IRE1α, especially under 
physiological conditions where the chances of having special kinds of genetic 
mutations and chemical compound activation are very rare. 
 
Previously there were controversial opinions about whether IRE1α activation 
is in the form of dimer or oligomers. One crystal structure of the kinase/RNase 
domain of Ire1 reveals a symmetric dimer with a back-to-back arrangement (318). 
This model dos not support autophosphorylation on the activation loop, because it 
positions the phosphorylation sites more than 40Å away (104). This study, 
showing the importance of phosphorylation on the activation loop, supports the 
oligomerization model. It was proposed that a rod-shaped assembly, with no 
known precedence among kinases, and kinase assembly trans-autophosphorylates 
subsequently order the RNase domain to create an interaction surface for mRNA 
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binding (104). It is possible that human IRE1α can be activated in the form of 
oligomers (334). 
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2.7.3 Summary of IRE1α mutants and corresponding XBP1s levels 
In order to identify the important residues responsible for IRE1α 
autophosphorylation upon activation and to identify the importance of 
phosphorylation for the RNase domain function, all possible residues in the kinase 
domain, activation loop and RNase domain were mutated. The following tables 
summarize the results of multiple western blot repeats of variable IRE1α mutant 
MEFs. P-IRE1α % is measured on phos-tag gels in an ER stress condition (Tg 
75nM for 3 hours). Raw data from each single repeat is shown in the table. XBP1 
mRNA splicing levels and protein levels are repeated once to twice each. Detailed 
methods are described in chapter 2.3. Representative figures of p-IRE1α, XBP1 
mRNA levels and XBP1 protein levels are shown in Appendix 2.7.2. 
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Table 1 Sum
m
ary of IR
E1α phosphorylation, X
B
P1 m
R
N
A
 splicing and protein levels w
ith m
utation(s) identified in cancers in the 
ER
 stress condition. 
L
ab 
N
um
ber 
Protein 
A
nnotation 
p-
IR
E
1α%
 
p-
IR
E
1α%
 
p-
IR
E
1α%
 
A
verage 
p-
IR
E
1α%
 
A
verage p-
IR
E
1α 
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X
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splicing 
X
B
P1s 
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PL
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5 
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+ 
+ 
++ 
PL
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0.7 
0 
0.8 
- 
- 
- 
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627 
L474R
 
99.4 
99.5 
  
99.5 
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Q
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no 
expression 
  
  
PL
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S769F 
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PL
660 
N
244S 
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*W
T “++++” is considered as 100%
. Every other result is com
pared w
ith W
T. “-” m
eans 0%
; “+” m
eans 1-25%
; “++” m
eans 
25-50%
; “+++” m
eans 50-75%
; “++++” m
eans 75-100%
. This applies to all the tables below
. 
 
 
      
104 
Table 2 Sum
m
ary of IR
E1α phosphorylation, X
B
P1 m
R
N
A
 splicing and protein levels w
ith m
utation(s) in the IR
E1α kinase 
dom
ain in the ER
 stress condition.  
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PL
525 
K
748A
 
100 
98 
89 
95.7 
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D
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+++ 
PL
607 
K
599A
/D
575K
 
2.1 
2 
2.3 
2.1 
+ 
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Table 3 Sum
m
ary of IR
E1α phosphorylation, X
B
P1 m
R
N
A
 splicing and protein levels w
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utation(s) in the IR
E1α activation 
loop in the ER
 stress condition. 
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Table 4 Sum
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3.1 ABSTRACT 
Alterations in endoplasmic reticulum (ER) homeostasis or ER stress have 
been causally linked to inflammatory responses but the physiological evidence in 
vivo remains to be demonstrated. ER-associated degradation (ERAD) is 
responsible for the clearance of misfolded proteins in the ER, thus essential for 
the maintenance of ER homeostasis. Using macrophage-specific ERAD-deficient 
mice, our data challenges the causal link between ER stress and inflammation in a 
physiological setting. We show that Sel-1 homolog 1 (Sel1L), a key protein 
component of the Sel1L-Hrd1 ERAD complex, is required for the clearance of 
misfolded proteins and the maintenance of ER homeostasis in macrophages. 
Although Sel1L-deficient macrophages exhibit elevated protein levels of a subset 
of ER chaperones and dilated ER cisternae at the basal conditions with increased 
sensitivity to ER stress upon challenge, to our surprise, these changes are 
uncoupled from inflammatory responses against bacterial pathogens both in vitro 
and in vivo, as well as in obese adipose tissues, pointing to a dispensable role for 
ERAD in macrophage inflammation. Thus, we conclude that physiological mild 
ER stress may not play a causal role in inflammation in macrophages.  
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3.2 INTRODUCTION 
Macrophages play a key role in inflammatory responses, such as 
autoimmunity, pathogen infection and obesity and type-2 diabetes. Indeed, it has 
been widely accepted now that macrophage activation dictates the quality, 
duration, magnitude and specificity of most, if not all, inflammatory responses. 
This is associated with two major functions of macrophages: First, macrophages 
phagocytose non-self antigens and act as professional antigen-presenting cells 
(APCs) via major histocompatibility complex (MHC)-peptide complexes to 
activate T lymphocytes of the adaptive immune system. Unpaired MHC class I 
molecule is a known misfolded protein that is normally cleared. Second, activated 
macrophages secrete a large amount of cytokines such as tumor necrosis factor α 
(TNFα), interferon γ (IFNγ), interleukin (IL) -6 and IL-1β, all of which are key 
mediators of inflammatory responses (335). ER associated degradation (ERAD) 
recognizes ER misfolded or unfolded proteins in the ER and translocate proteins 
while ubiquitylating the substrates to be finally degraded in proteasome and 
ERAD is activated upon UPR (336).  As the biosynthesis, folding and maturation 
of MHC protein and most cytokines occur in the endoplasmic reticulum (ER), we 
hypothesized that ERAD plays a critical role in macrophage innate immunity 
functions.  
 
Indeed, ER stress response or unfolded protein response (UPR) has been 
implicated in macrophage function in inflammatory responses and metabolic 
diseases (235, 337). Upon lipopolysaccharide (LPS) stimulation, UPR may be 
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activated in Toll-like receptor (TLR)-dependent manner and the IRE1α-XBP1 
pathway of the UPR is required for the innate function (i.e. cytokine 
transcription/production) of macrophage (298). In X-box binding protein 
1(Xbp1)-deficient macrophages, cytokine mRNA levels were impaired (298). 
Recently, UPR activation has been linked to inflammation, although the 
underlying mechanism is less well defined. ER stress activation may lead to the 
activation of JNK and NF-κB (285, 288, 338), both of which are key mediators of 
inflammation. Moreover, ER stress or IRE1α activation was recently directly 
linked to inflammasome activation in β cells and macrophages (339, 340), which 
may contribute to the cell death that occurs with prolonged treatment of 
pharmacological ER stress inducers (341, 342). However, as most studies used 
high nonphysiological concentrations of ER stress inducers such as thapsigargin, 
tunicamycin and DTT, whether ER stress plays a role in inflammation in vivo 
under various physiological settings remains to be demonstrated.  
 
ER-associated degradation (ERAD) machinery recognizes, translocates and 
degrades misfolded proteins in the ER, acting as a component of the ER quality 
control system, and is critical for the maintenance of ER homeostasis (134). At 
least 10 different ubiquitin ligases have been implicated in ERAD in mammals 
(134, 343). Perturbations of ER homeostasis (caused by disturbance of ERAD, 
protein folding capacity, ER microenvironment etc) culminate in ER stress and 
activate the UPR (63, 344). Although the nature of substrate recognition and the 
physiological role of the complex in vivo largely remain unknown, recent studies 
using model antigens have shown that each ERAD system is responsible for a 
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subset of overlapping substrates. The physiological roles of ERAD in vivo and in 
macrophages have not been studied so far.  
 
The most well-characterized ERAD machinery is composed of Hrd1 E3 
ubiquitin ligase, and its complex with the Sel1L protein, an adaptor protein that 
regulates both stability and substrate specificity of Hrd1 (135, 345, 346). Sel1L 
and its function are highly conserved from yeast to humans (347). Mammalian 
Sel1L/yeast Hrd3 encodes an ER-resident single transmembrane protein with a 
large luminal domain and a short cytosolic tail (348, 349). Both mammalian 
Sel1L and yeast Hrd3 form a complex with E3 ubiquitin ligase Hrd1 and are 
responsible for the degradation of a subset of misfolded proteins in the ER (135, 
166, 196, 350). While Hrd3-deficient yeast and Sel1-deficient worms are viable 
(135, 178, 346, 351), Sel1L-deficient mice are embryonic lethal (352). Variants in 
the Sel1L gene have been identified in Japanese patients with autoimmune thyroid 
diseases (353), and Sel1L has been identified as a candidate gene for canines and 
humans with progressive early-onset cerebellar ataxia (354) and Alzheimer’s 
disease (355). Nonetheless, the physiological significance of the Sel1L-Hrd1 
complex in vivo remains unknown.  
 
One significant difference between ERAD-deficient animal models and UPR-
deficient mice (such as IRE1α-, PERK-, Xbp1-null and etc) is that ERAD-
deficient cells are capable of mounting strong UPR in the face of accumulation of 
misfolded proteins in the ER, whereas UPR-deficient cells or mice are not.  Upon 
accumulation of misfolded proteins (due to ERAD failure), the activation of UPR 
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branches may collectively alleviate misfolded protein load by elevation of ER 
chaperones (such as GRP78, calnexin and ERp57 and etc), expansion of ER 
membranes and attenuation of protein synthesis; if stress persists, cells may 
undergo apoptosis. 
 
To study the role of Sel1L in ERAD and inflammation, we generated myeloid 
cell-specific Sel1L-deficient mice (MKO). We initially hypothesized that Sel1L 
deficiency in macrophages may lead to activation of the UPR, which may directly 
induce inflammatory responses. However, here we report a surprising finding 
that, although ERAD is essential for ER homeostasis, MKO macrophages have 
normal cytokine secretion, antigen presentation, pathogen defense, and other 
innate immunity functions both in vitro and in vivo. Thus, our findings suggest a 
dispensable role of HRD1/Sel1L ERAD complex in macrophages inflammatory 
responses. 
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3.3 EXPERIMENTAL PROCEDURES 
 
Mice   The Sel1Lflox/+ ES cells on the C57BL/6N background were purchased 
from the KOMP Repository Project (ID CSD44577, UC Davis, 
http://www.knockoutmouse.org/martsearch/project/44577). Exon 6 of Sel1L gene 
was flanked with two loxP sites (floxed). The lacZ-neo cassette was deleted by 
crossing the animals onto the βActin-FLPe deleter mice (356). The Sel1Lflox/flox 
animals were then crossed with myeloid-specific Lyz2-Cre mice (B6.129P2-
Lyz2tm1(cre)Ifo/J, JAX 004781), which have been backcrossed onto the 
C57BL/6J background for more than 5 generations prior to arrival at our facility. 
The last stage of cross generated MKO and the control cohort Sel1Lflox/flox 
littermates without Cre (termed “WT” hereafter) at 1:1 ratio.  HFD contained 60% 
fat, 20% carbohydrate and 20% protein (Research Diet D12492) while ND 
consisted of 13% fat, 67% carbohydrate and 20% protein (Teklad 2914). All 
animal procedures have been approved by the Cornell IACUC (#2007-0051).  
 
Preparation of Primary Macrophages    Peritoneal macrophages were 
obtained 4 days after intraperitoneal injection of 2 ml aged 4% brewed 
thioglycollate broth (Inc and catalog #). Mice were euthanized by CO2 and the 
abdomens were soaked with 70% alcohol. Retract the abdominal skin manually to 
expose the intact peritoneal wall, and use 6-ml syringe with room temperature 
PBS to inject along the left side of peritoneal wall, and fluids were aspirated and 
removed to regular polypropylene centrifuge tubes. Centrifuge the peritoneal 
exudate cells (PEC) at ~1,000 rpm for 10 min. 200 µl lysis buffer for red blood 
cells was added to the cell suspension after centrifuge, and the reaction was 
stopped by the addition of 15 ml PBS. Peritoneal macrophages were counted 
using hemocytometer. 3X106 cells were plated in each well of a 6-well plate for 
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western blot or other biochemistry analysis.  For bone marrow derived 
macrophages (BMDM), femur bones were collected and flushed with a 27 1/2-
gauge needle. After centrifugation, cells were seeded onto 10-cm Petri dishes at 
approximately 1X107 cells/plate in DMEM (Sigma) containing 10% FBS and 
20% L929 cell conditioned media as a source of macrophage colony-stimulating 
factor (M-CSF) for 5-8 days. Flow cytometric analysis shows that nearly 95% 
cells were BMDM.  
 
Drug Treatment and Cell Culture   Thapsigargin (Tg, EMD Calbiochem) 
was dissolved 0.6 mM in DMSO. Lipopolysaccharides (LPS, Sigma L4130) was 
dissolved in culture media at 1 µg/ml.  Aliquots were stored at -200C.  MG-132 
(FISHER NC9937881) was dissolved in DMSO at 10mM and stored at -800C. In 
most experiments, cells were treated with various drugs over a time course as 
indicated in the figures and figure legends.  
 
Transmission Electron Microscopy (TEM)    Peritoneal macrophages were 
seeded on 6 well plates as described above with 15X106 cells each well and fixed 
with 5% glutaraldehyde, 4% paraformaldehyde in 0.1M phosphate buffer for 2 h 
and post fix in 1% osmium tetroxide in 0.1 M phosphate buffer. The further 
processing and imaging acquisition were performed on a fee-for-service basis by 
the Electron Microscopy & Histology Core Facility at Weill Cornell Medical 
College.  
 
Western Blot and Image Quantitation    Preparation of cell lysates, PPase 
treatment and Phos-tag and regular Western blot were performed as previously 
described (322, 324). IRE1α phosphorylation allows directly visualization of ER 
stress response and accurate assessment of stress in the ER (322, 324, 325). 
Antibodies used in this study: HSP90 (rabbit, 1:5,000), GRP78 (goat, 1:1000), 
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Caspase 3 (rabbit, 1:2,000) from Santa Cruz; IRE1α (rabbit, 1:1,000), PERK 
(rabbit, 1:1,000), eIF2α p-Ser51 (rabbit, 1:2000), eIF2α (rabbit, 1:2000), LC3B 
(rabbit, 1:1000), IκBα (rabbit, 1:2000), ACC (rabbit, 1:2000) from Cell Signaling; 
Sel1L (rabbit, 1:1,000) from Abcam; HRD1 (rabbit, 1:8000) from Novus 
Biologicals; PDI (rabbit, 1:10,000), ERp57 (rabbit, 1:2,000), Calnexin (rabbit, 
1:10,000) from Assay Design; Hsp70 (mouse 1:1,000) from LifeSpan 
BioSciences; Derlin1 (rabbit, 1:5,000) and Derlin2 (rabbit, 1:5,000), gifts from H. 
Ploegh (MIT); iRhom2 (rabbit, 1:5,000), a gift from M. Freeman (Cambridge, 
UK). Of note, to ensure sufficient signal for cleaved caspase 3, the membrane for 
caspase 3 was cut around the 25 kDa line and then probed separately with caspase 
3 antibody. Band density was quantitated using the Image Lab software on the 
ChemiDOC XRS+ system (Bio-Rad) and presented as mean ± SEM from several 
independent experiments or as representative data from at least two independent 
experiments.    
 
RNA Extraction and qPCR    RNA from cells and tissues were extracted 
using Trizol and Qiagen RNA miniprep kit and performed as previously described 
(322). qPCR primer sequences have been previous reported (322, 324). 
 
Cell Survival Assay    3X106 peritoneal macrophages in wells of 6 well plate 
were treated with Tg 300nM for 6.5 hour. Scrape the cells up, and count cell 
number to plate 1X106 in a 10cm dish and change fresh media every 3 days. 12 
days later, the cells were briefly washed in PBS and fixed in freshly prepared 
3.7% formaldehyde in PBS for 15 min followed by 30 min incubation in 0.05% 
crystal violet in distilled water (filtered before use) with gentle rocking at room 
temperature. Cells were washed 3 times for 5 min each with ddH2O, 
permeabilized with methanol for 15 min and sampled aliquots were read at OD 
540 nm with Bio-Tek Synergy 2 plate reader (Bio-Tek Inc.). 
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Brefeldin-A BODIPY, Cell Surface Marker Analysis and Flow Cytometry 
Cells were incubated at 370C for 30 - 45 min with 0.4 µg/ml Brefeldin A-
BODIPY (Invitrogen) in culture media followed by flow cytometric analysis 
using a BD FACSCalibur flow cytometer. For surface marker analysis, 
fluorochrome- or biotin- conjugated antibodies against CD4 (GK1.5), CD8 
(YTS169), F4/80 (BM8), CD11b (M1/70), Gr1 (RB6-8C5), B220 (RA3-6B2), 
CD45 (30-F11), CD69 (H1.2F3), and isotype control antibodies were purchased 
from BioLegend, UCSF Flow Core Facility or BD Biosciences. Following 
incubation with anti-CD16/CD32 antibody to block Fc receptors, 1×106 cells were 
incubated with 20 µl of antibodies diluted at optimal concentrations for 20 min at 
40C. Cells were washed three times with PBS and then resuspended in 200 µl PBS 
for analysis. Data was analyzed using the CellQuest and FlowJo software.  
 
T cell and NKT Cell Activation Assay BMDM from both WT and MKO 
were cultured in 96 well (4x105 BMDM/well), as well as 4x105 CD8+ T cells, 
isolated from OT1 mouse splenocytes. To each well, 5uM OVA257-264 
(SIINFEKL, Biomatik) or CON-DMEM (not shown) were added and incubated in 
37°C incubator for 48 hours. The supernatant was collected at the end of 
incubation and analyzed for IL-2 analysis using ELISA. (C) NKT cells 
(1*10^4/well) and 1*10^5 peritoneal macrophages were co-cultured in a 96 well 
for 12 hours and culture medium were then spin and collected for analyzing IL-2 
by ELISA. 
 
LPS Challenge   8-w-old female mice were injected i.p. with LPS at 40mg/kg 
body weight and observed for survival every 4 h. In some experiments, 200 µl 
serum was collected at 0, 3 and 6 h time points post injection for cytokine 
analysis. 
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Listeria monocytogenes Infection    Mice were anesthetized with isofluorane 
and infected with 104 Listeria monocytogenes strain 10403S by retro-orbital 
injection.  Mice were sacrificed at 3 days post-infection and blood, liver and 
spleen were collected.  Tissues were homogenized in 0.05% NP-40 solution and 
serial dilutions were plated on LB-agar to determine bacterial loads.  Cytokines 
levels of TNFα and IFNγ in serum were quantified using eBioscience Ready-Set-
Go ELISA kits. 
 
Cytokine Analysis   TNF-α, IL-6 and IL-1β ELISA kits were purchased from 
eBioscience or Biolegends.  All ELISAs were performed per supplier’s protocols. 
 
Inflammasome Activation    Inflammasomes activation, in vivo and in vitro, 
was performed as previously described (357). Briefly, 8w-old mice were injected 
i.p. with LPS at 2 ng/g BW (Sigma L4130) 1.5 h prior to the ATP challenge i.p. 
(50mM ATP, adjusted to pH 7 with NaOH, Sigma) at 10µl per gram of body 
weight. 1 h later, mice were euthanized. Blood and peritoneal lavage fluid were 
collected to measure cytokines and Gr-1+ CD11b+ neutrophils. The IL-1β level 
was measured by ELISA and the neutrophil levels were measured by the flow 
cytometer. In vitro, peritoneal macrophages were treated with 0.1 µg/ml LPS 
(Sigma L4391) for 5 h followed by addition of 5 mM ATP (Sigma) for 30 min 
followed by protein extraction. 
 
H&E Staining    Tissues were collected at what condition and fixed in 10% 
formaldehyde and sent to Cornell Histology Core Facility for sectioning and HE 
staining on a fee-for-service basis. Pictures of HE staining sections were taken by 
a Leica microscope (Leica Microsystems, Buffalo Grove, IL). 
 
  
 
 
 
 
118 
Glucose/Insulin Tolerance Test (GTT/ITT) Male mice on HFD for 20 
weeks (from the age of 8 weeks) were subjected to the glucose tolerance test 
(GTT). Mice were fasted for 18 hours before the test, and injected i.p. glucose 
(Sigma) 1 g/kg body weight. During ITT, mice were fasted… Blood glucose was 
monitored using One-Touch Ultra Glucometer at 0, 30, 60, 90 and 120min post-
injection.  
 
Statistical Analysis      Results are expressed as mean ± SEM unless indicated 
otherwise. Comparisons between groups were made by unpaired two-tailed 
Student’s t-test, where p < 0.05 was considered as statistically significant. All 
experiments were repeated at least two to three times and representative data are 
shown. 
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3.4 RESULTS 
Generation of myeloid-cell specific Sel1L-deficient (MKO) mice.   In 
macrophages, Sel1L is a transmembrane glycoprotein residing in the endoplasmic 
reticulum (346, 352) as confirmed by its complete sensitivity to endoH (Figure 
3.1A). It is expressed in embryonic and cancer cells (348, 358-360), as well as 
organs with a high protein secretion function (Figure S3.1A). During the process 
of cell differentiation, from bone marrow progenitor cells into mature 
macrophages with the stimulation of CSFs (colony-stimulating factor produced by 
L929 cell lines), Sel1L protein level increased (Figure S3.1B), indicating its 
important role in BMDM. ER stress, but not LPS, induced Sel1L mRNA levels by 
50% (Figure 3.1B). To study the role of Sel1L/HRD1 ERAD complex in 
macrophages inflammatory responses, we generated myeloid-cell specific Sel1L 
KO mice, hereafter termed MKO mice. In the Sel1Lflox/+ ES cells, exon 6 of Sel1L 
gene was flanked with two loxP sites (Sel1Lflox/flox) (Figure 3.1C).  The 
Sel1Lflox/flox animals were crossed with myeloid-specific Lyz2-Cre mice. The last 
stage of crosses generated MKO and the control cohort Sel1Lflox/flox littermates 
without Cre (termed WT hereafter) at 1:1 ratio as expected (Figure 3.1F). 
Western blot analysis revealed significant reduction of Sel1L protein in bone 
marrow-derived macrophages and thioglycollate-elicited peritoneal macrophages 
of MKO mice compared to WT mice, but not in other tissues (e.g. liver, spleen, 
and pancreas, Figure 3.1D). Of note, it is not clear what the bands underneath 
Sel1L bands are. They could be non-specific bands bound by Sel1L antibodies, or 
could be unknown alternatively spliced isoforms of Sel1L. However, the size of 
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these lower bands does not match any Sel1L isoforms that are currently known 
(348). MKO mice on low-fat diet (LFD) appeared normal and exhibited no body 
weight differences up to 16 weeks of age (Figure 3.1E). The amount of myeloid-
derived macrophages and neutrophils in spleens of naïve or thioglycollate-
challenged mice were comparable between MKO and WT mice (Figure 3.1G, 
Figure S3.2), suggesting that Sel1L deficiency does not affect myeloid cell 
differentiation and proliferation. Finally, total peritoneal macrophages cell 
numbers were the same between the two cohorts (Figure 3.1H). This indicates 
that Sel1L deficiency does not affect myeloid cell activation and infiltration. 
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Figure 3.1 Characterization of MKO mice.  
(A) Sel1L protein is sensitive to endoH in peritoneal macrophages. (B) Sel1L 
mRNA level induced by Thapsigargin (Tg) and lipopolysaccharide (LPS) 
measured by qPCR. (C) Schematic gene structure of mouse Sel1L manipulated in 
transgenic mice. Exon 6 was flanked with two floxP sites. Exons are shown in 
purple and introns in black line. (D) Sel1L expression level in different tissues in 
WT and Sel1L KO mice. (E) Growth curve (body weight) of WT and MKO from 
week 3 to 9 after birth. (WT n=10, MKO n=6) (F) Observed ratio of birth between 
WT and MKO mice was consistent with expected ratio. (G) Naïve or 
Thioglycollate-injected mice spleen were dissected and performed FACS. CD11b, 
Gr1 and F4/80 antibodies were used to gate and quantify the percentage of 
macrophages. (H) Cell count of collected peritoneal macrophages from each WT 
(n=5) and MKO (n=5) mouse. 
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ERAD deficiency and alterations in ER homeostasis in Sel1L deficient 
macrophages. (Thereafter Sel1L deficient macrophages are referred to as MKO 
macrophages, and Sel1L myeloid-cell specific knock-out mice are referred to as 
MKO mice). In line with the observations in yeast (135) and in mammalian cell 
lines (345, 350), but in contrast to one mammalian cell study (361), loss of Sel1L 
significantly reduced the level of Hrd1 by 50-60% in macrophages (Figure 3.2A-
B), highlighting the importance of Sel1L in Hrd1 stability and in the formation of 
the HRD1 ERAD complex. Sel1L deficiency had few effects on other ERAD 
components. Derlin 1 and 2 protein levels were only slightly affected (by 20-
30%) in Sel1L-deficient macrophages (Figure 3.2B).  
 
 To directly visualize ER homeostasis, we next performed transmission 
electron microscopy (TEM) to visualize organelle morphology in cells. 
Dramatically, ER cisternae in the MKO cells were dilated (arrows in Figure 
3.2D). The normal flat cisternae of ER are expanded into a ballooned structure in 
Sel1L KO peritoneal macrophages. In the ER of MKO macrophages, we also 
noticed significantly higher luminal density, possibly representing an 
accumulation of misfolded proteins (Figure 3.2D). There was no difference in 
cell size and intracellular granule particles between the two cell groups (Figure 
3.2D). In addition, Sel1L KO macrophages showed normal numbers of 
mitochondria with no differences in average size and morphology (Figure S3.3), 
suggesting that mitochondrial reactive oxygen species (ROS) were unlikely to 
cause an increase of proinflammatory cytokine production (362, 363) in this case. 
We also measured ER expansion in MKO peritoneal macrophages by the flow 
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cytometer using ER/Gogi mass specific Brefeldin A-Bodipy staining (Figure 
3.2C). 
 
We then determined the consequence of Sel1L-Hrd1 ERAD deficiency on ER 
homeostasis. To this end, we either mock-treated or treated primary macrophages 
(bone marrow-derived (BMDM) and thioglycollate-elicited peritoneal 
macrophages) obtained from WT and MKO mice with thapsigargin (Tg) or 
lipopolysaccharides (LPS) to induce ER stress and inflammation, respectively. 
Interestingly, while PDI and calnexin protein levels were not affected (Figure 
3.2F), a subset of ER chaperones including ERP57 and GRP78 were upregulated 
by 2-4 fold in MKO macrophages (Figure 3.2E), indicating a chaperone specific 
effect in resetting ER homeostasis. Similar results were confirmed by qPCR 
measuring GRP78, Grp58 and Calnexin mRNA levels (Figure S3.4). Under the 
condition treated, cytosolic chaperones such as HSP70 were not affected by Sel1L 
knock-out (Figure 3.2F), pointing to a specific effect of Sel1L on resetting ER 
homeostasis. 
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Figure 3.2 ERAD deficiency and alterations in ER homeostasis in MKO 
macrophages.  
(A) Thioglycollate induced peritoneal macrophages and bone marrow derived 
macrophages (BMDM) were cultured and treated by Thapsigargin (Tg, 300nM) 
or lipopolysaccharides (LPS, 1000ng/ml) for 4 hours or as indicated time course. 
Whole cell lysates were extracted and performed SDS-page western blots.  Data 
were representative of 2 independent experiments. Both peritoneal macrophages 
and BMDM showed decreased HRD1 protein levels in MKO. Quantification of 
untreated state was shown in numbers below. (B) WT and MKO peritoneal 
macrophages and BMDM were treated by LPS in 2, 4, 6, 8 hours and western 
blots showed MKO Derlin 1 and Derlin 2 level remained comparable to WT. (C) 
FACS data of WT and MKO peritoneal macrophages stained with Brefeldin A-
Bodipy showed increased ER size in MKO (n=4). Quantification of mean 
fluorescence index (MFI) was listed below. (D) Representative TEM images of 
peritoneal macrophages.  Scale bar was shown in the picture. Arrows indicated 
ER, N indicated nucleus. (E) (F) WT and MKO peritoneal macrophages and 
BMDM were treated in the same condition as (A). Western blots showed up-
regulation of ER chaperones ERP57 and GRP78, but not PDI ad Calnexin. 
Quantification of untreated state data shown in numbers below. HSP90, HSP70 
were loading controls. 
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Increased sensitivity to ER stress induced cell death in MKO 
macrophages.  We next directly assess the activation status of UPR pathways, 
mostly the IRE1α and PERK pathways as we previously described (324). A 
dramatic increase of IRE1α protein was observed in both MKO peritoneal 
macrophages and bone marrow derived macrophages (BMDM) by 10-30 fold 
(Figure 3.3A-B), similar to the Xbp1- or Derlin 2- deficient cells (79, 364). 
However, the absolute amount of phosphorylated IRE1α in MKO macrophages 
under basal conditions was comparable to that in WT, but the amount of p-IRE1α 
was highly increased in MKO cells compared to WT cells with Tg treatment 
(Figure 3.3A-C). However, the percent of total IRE1α that was phosphorylated 
was reduced in MKO cells at both basal and Tg-treated conditions, reflecting up-
regulation of IRE1α in MKO cells (Figure 3.3A-C). Xbp1 mRNA splicing was 
significantly elevated in MKO macrophages compared to WT macrophages under 
basal conditions (Figure 3.3D), while upon ER stress challenge, Xbp1 mRNA 
splicing was comparable between the two cell groups (Figure 3.3D). 
Consistently, MKO macrophages showed an increase in Xbp1s, ATF4 and CHOP 
transcription factors (Figure 3.3E). Similar to the IRE1α pathway, total PERK 
protein increased over 4-6 fold in MKO macrophages (Figure 3.3F). Slight 
mobility-shift of PERK protein was noted in MKO cells at both basal and Tg-
treated conditions (Figure 3.3F). Phosphorylation of e-IF2α, a downstream of the 
PERK pathway, was not elevated in Sel1L KO macrophages (Figure 3.3G). 
While the underlying mechanism for IRE1α and PERK accumulation in MKO 
macrophages remains unclear, our data demonstrated that IRE1α and PERK 
signaling pathways were modestly elevated in MKO macrophages compared to 
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the WT cohorts. To be noted, the accumulation of IRE1α and PERK protein in 
MKO were not only due to the ERAD defect, as blocking cytosolic proteasome by 
MG-132 only induced a mild increase of IRE1α and PERK (Figure S3.5). 
Moreover, the half-life of IRE1α, PERK, GRP78 and HRD1 seem to be shorter in 
Sel1L KO macrophages compared to WT (Figure S3.6). Since the mRNA level 
of IRE1α and PERK is not induced in MKO (Figure S3.4), we assume IRE1α and 
PERK protein degradation might be dependent on Sel1L/HRD1. At the 
transcription level, some chaperones such as GRP78 was elevated, while others 
were unaffected at the basal conditions (Figure S3.4). Overall, WT and MKO 
cells exhibited similar ER stress-induced transcription profiles (Figure S3.4). 
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Figure 3.3 Sel1L/HRD1 ERAD deficiency caused a mild UPR activation in MKO 
macrophages.  
Thioglycollate induced peritoneal macrophages and bone marrow derived 
macrophages (BMDM) were cultured and treated by Thapsigargin (Tg, 300nM) 
or lipopolysaccharides (LPS, 1000ng/ml) for 4 hours or as indicated time course. 
Whole cell lysates were extracted and performed SDS-page western blots.  Data 
were representative of 2 independent experiments. Western blot showed 
peritoneal macrophages (A) and BMDM (B) p-IRE1α in phos-tag gels, total 
IRE1α and loading control hsp90 on regular SDS page gel. Cell lysates were 
treated with/without λPPase. The absolute amount of p-IRE1α and p-IRE1α/total 
IRE1α were shown in (C). N/A, non-treated control. (D) XBP1 splicing by RT 
PCR under basal condition, Tg and LPS treatment. Quantification of XBP1s/total 
XBP1 was shown below. (E) Nuclear extraction protein lysates run on western 
blots showed transcription factors XBP1s, ATF4 and CHOP. (F) PERK protein 
levels in both peritoneal macrophages and BMDM from WT and MKO mice 
under the listed treatment conditions. (G) p- or total eIF2α protein levels in both 
peritoneal macrophages and BMDM from WT and MKO mice under listed 
treatment conditions. Quantification of p/total eIF2α in BMDM was shown on the 
right side. 
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As ER stress is linked to cell death (63), we next asked whether MKO cells 
are predisposed to cell death. Surprisingly, at the basal condition, MKO cells 
exhibited similar levels of caspase-3 cleavage (Figure 3.4A,C) and Annexin V 
levels (Figure 3.4F). However, MKO cells exhibited increased caspase-3 
cleavage and Annexin V levels under ER stress condition (Figure 3.4A-B, D, F) 
but not with LPS stimulation (Figure 3.4C, E, F). 
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Figure 3.4 Increased sensitivity to ER stress in MKO macrophages. 
 (A) Peritoneal macrophages were treated by Thapsigargin (Tg, 300nM) for 
the indicated time course. Western blot for pro- and cleaved form of caspase-3 
were shown in (A). Quantification of cleaved caspase-3 was shown in numbers 
below. (B) For the same conditions as (A), western blot for RIP3 and RIP1. (C) 
Peritoneal macrophages were treated by LPS (1000ng/ml) for a time course as 
listed. Western blots showed pro- and cleaved form of caspase-3, RIP3, RIP1, 
LC3-B and quantification of caspase-3 was shown in (E).  (F) FACS data showed 
the percentage of Annexin-V positive peritoneal macrophages in the conditions 
listed. 
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Normal immune functions of MKO macrophages in vitro. As macrophages 
play a key role in both innate and acquired immunity, we next asked how Sel1L 
deficiency affects immune functions of macrophages such as antigen presenting 
and cytokine secretion upon stimulation.  Macrophages are professional antigen 
presenting cells to process peptide and lipid antigens and present them in complex 
with MHC class I/II and CD1d proteins to activate CD8+, CD4+ T cells and 
natural killer T (NKT) cells, respectively. Assembly and maturation of MHC class 
I/II and CD1d proteins occurs in the ER, as well as the loading of endogenous 
peptides onto the MHC class I molecules. Thus, we anticipated that Sel1L 
deficiency might affect antigen presentation function of macrophages via the 
regulation of the assembly, maturation and presentation of MHC-peptides or 
CD1d-lipid complexes. 
 
To our surprise, protein levels of MHC class I and II molecules at the 
cellular surface were comparable between MKO and WT macrophages (Figure 
3.5A).  In a co-culture system with both macrophages and CD8+ T cells, 
supplemented with corresponding ovalbumin 257-264 (SIINFEKL) peptides, 
there was no difference in the activation of CD8+ T cells, because IL-2 released 
from the CD8+ T cells showed no differences (Figure 3.5B). Similarly, when 
pulsed with lipid agonist α-galactoceramides (αGalCer, binds to CD1d), MKO 
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cells had no defect in activating NKT cell line DN32 (Figure 3.5C). Thus, these 
data showed that despite the dilation of the ER, the assembly and maturation of 
functional surface MHC-peptide complex and antigen presentation by MHC class 
I and CD1d molecules were not compromised by Sel1L deficiency. 
 
We next examined the immunological response to LPS. Sel1L protein 
levels were not changed upon the stimulation of various Toll-Like Receptors 
(TLR) agonists (Figure S3.7A). In vitro, LPS increased inflammation in both 
MKO and WT macrophages at a comparable level and dynamic pattern, as shown 
by IΚappaB (Figure 3.5D-E) and p-JNK (Figure S3.7B). Commassie blue 
staining of secreted proteins in the culture medium of WT and MKO macrophages 
revealed comparable levels of overall protein secretion in response to LPS and Tg 
(Figure 3.5F). Furthermore, Tumor Necrosis Factor alpha (TNFα) and 
Interleukin-6 (IL-6) secreted by MKO macrophages in response to LPS were 
similar to those of WT macrophages (Figure 3.5G). At the molecular level, an 
ER-transmembrane protein iRhome2, a key regulator of TNFα activation (365, 
366), was not altered in MKO macrophages (Figure 3.5H). Thus, these data 
strongly support that Sel1L deficiency does not affect LPS-induced acute 
macrophage activation and inflammatory cytokine secretion.  
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Figure 3.5 Normal innate function of MKO macrophages in vitro.  
(A) Peritoneal macrophages were collected fresh from both WT and MKO 
mice and performed FACS to detect MHC-I and II expression levels. (B) BMDM 
from both WT and MKO were cultured in 96 well (4x105 BMDM/well), together 
with 4x105 CD8+ T cells that were isolated from OT1 mouse spleens. To each 
well, 5µM OVA257-264 (SIINFEKL, Biomatik) or control-DMSO (data not 
shown) were added and incubated in 37°C incubator for 48 hours. The culture 
medium was collected at the end of incubation and ELISA was performed to 
measure IL-2. (C) NKT cells (1x104/well) and 1x105 peritoneal macrophages 
were co-cultured in a 96 well for 12 hours and the culture medium was pulsed 
with lipid agonist α-galactoceramides. Then the medium was collected for 
analyzing IL-2 by ELISA. (D) Western blot showed IκB levels of peritoneal 
macrophages treated with LPS by indicated time points. Hsp90, a loading control. 
Quantification of IκB/Hsp90 was shown in (E). (F) BMDM were cultured on 10 
cm plates (18x106/dish) and treated with Tg or LPS in DMEM without FBS for 4 
hours. The culture medium was then collected and concentrated from 6ml to 
100µl and run a SDS-page gel, followed by Commassie Blue Staining. (G) 
Stimulated by LPS in a time course, macrophage cytokine TNFa and IL-6 levels 
in culture medium were analyzed by ELISA. (H) Protein levels of iRhom2 in 
WT/MKO BMDM in basal level, Tg and LPS treatments. ACC, a loading control. 
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Sel1L is not required for inflammatory responses against pathogens in 
vivo. Next we examined the whole body responses to LPS endotoxin shock and 
the listeria pathogen infection, the outcome of which were known to be 
determined by the function of macrophages (365, 366).  First, WT and MKO mice 
were challenged with LPS. MKO mice exhibited no difference from WT 
littermates in survival rate with 100% death within 24 hours (Figure 3.6A). 
Serum cytokine levels (TNFα, IL-6 and IL-1β) were dramatically induced within 
hours post injection, which were not different between WT and MKO mice 
(Figure 3.6B). Second, we challenged mice with L. monocytogenes, an 
intracellular anaerobe causing listeriosis (367). There were no differences in 
bacterial load in the liver and spleen (Figure 3.6C).  Moreover, serum levels of 
IFNγ and TNFα were also comparable (Figure 3.6D). Taken together, our data 
demonstrated that macrophage innate immunity functions against pathogens in 
vivo were not perturbed by Sel1L deficiency and alterations in ER homeostasis. 
 
In addition, inflammasomes have been shown to be activated upon both 
bacterial and viral infections, and inflammasomes activation was known to be 
dependent on monocytes and macrophages (368-373). Here, we also tested in 
vivo inflammasome activation by an LPS and Adenosine Triphosphate (ATP) 
two-step signaling model. Macrophages and dendritic cells need a TLR-ligand 
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activation to induce pro-IL-1β transcription and a second signal ATP to induce 
caspase-1 cleavage that leads to IL-1β maturation and secretion (357, 374). We 
were surprised to find no severe activation of inflammasomes in MKO mice in 
vivo (Figure 3.6E). Although there was an increase of TNFα both in the serum 
and lavage fluid, IL1β levels, as well as the number of total cells, neutrophils, 
macrophages, B cells, and T cells were all the same between MKO and WT 
groups. In addition, the cellular surface and intracellular ATP receptor P2X7 
levels remained similar between WT and MKO cells (Figure S3.8), consistent 
with the results that showed similar levels of pro-inflammatory cytokines and 
MHC class I proteins (374-376). These results thus prove there was no defect or 
enhancement of inflammasomes activation in Sel1L MKO mice; indicating Sel1L 
in macrophages is dispensable for the maintenance of normal inflammasomes 
function in vivo. 
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Figure 3.6 Sel1L is not required for inflammatory responses against pathogens in 
vivo. 
(A) Survival curve of MKO and WT mice that were challenged by 40mg/kg 
LPS in an endotoxin shock model. (B) Serum levels of TNFa, IL-6 and IL-1b at 
the indicated time points from mice challenged with LPS. (C) Tissue bacterial 
burdens from both WT and MKO mice at the third day post Listeria. 
monocytogenes infection. (D) Cytokine levels of IFNγ and TNFα in serum 3d 
post-infection as analyzed by ELISA. (E) 8w-old mice were injected (i.p.) with 
LPS, and 1.5 h later injected with ATP, then after 1 hour, the blood and peritoneal 
lavage fluid was collected. ELISA was performed to measure cytokines IL-1β and 
TNFα. Total cell number, Gr-1+ CD11b+ neutrophils, F4/80+ macrophages, B220+ 
B cells, and CD4+ or CD8+ T cells numbers were all measured by the flow 
cytometer. 
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Sel1L in macrophages is not required for chronic inflammatory responses 
in obesity. ER stress in adipose tissue and the liver has been causally linked to 
obesity-induced type-2 diabetes (219, 377). Indeed, chemical chaperones that may 
help protein folding have been shown to be effective in treating type-2 diabetic 
mouse models (377). In obesity, macrophage infiltration into white adipose tissue 
(WAT) may play a significant role in the development of inflammatory tone in 
the adipose tissue and hence insulin resistance (378-380). Based on these studies, 
we postulated that Sel1L deficiency in macrophages might influence adipose 
inflammation in obese animals.  
 
To this end, mice were placed on a 60% high fat diet (HFD), in which 
60% calories were derived from fat for up to 20 weeks. There was no difference 
in body and liver/adipose weight between MKO and WT mice upon 20-week 
HFD feeding (Figure 3.7A-C). Histological assessment of WAT revealed 
comparable levels of immune cell infiltration (Figure 3.7D), which was further 
confirmed by Q-PCR and Western blot analyses of macrophage markers and 
inflammatory genes in WAT (Figure 3.7E-F). No dramatic difference in 
morphology was observed in the liver as assessed by H&E staining (Figure 3.7D). 
Serum cytokine levels of IL-6 and TNFα were comparable (Figure 3.7G), 
indicative of comparable systemic inflammatory responses. Finally, glucose and 
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insulin tolerance as measured by glucose tolerance test (GTT) and insulin 
tolerance test (ITT) were similar between the two cohorts (Figure 3.7H-I). Taken 
together, our data supported that macrophage Sel1L is dispensable for adipose 
inflammation in obesity. 
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Figure 3.7 Sel1L in macrophages is not required for chronic inflammatory 
responses in obesity.  
WT and MKO mice (n=6 each) were set on HFD from week 6 continuously 
till week 20. (A) Body weight (B) Percentage of WAT weight and (C) Percentage 
of liver weight of WT or MKO mice. (D) HE staining of WAT and liver tissue 
sections of MKO or WT mice fed on HFD. (E) Western blots of Arginase 1 (Arg 
1), I-kappa-B (IκB), phosphorylated JNK (p-JNK), total JNK and IRE1α in WAT 
after 20w HFD. Quantification of proteins as normalized to hsp90 was shown at 
the right side. (F) Q-PCR showed M1 M2 gene markers in WAT tissue in MKO 
and WT mice fed on HFD. (G) Serum TNFα and IL-6 levels were measured by 
ELISA. (H) Serum glucose level and insulin level after 18 hours fasting. (I) GTT 
and ITT in MKO or WT mice fed on HFD. Values represent mean ± S.E. *, p < 
0.05, and ***, p < 0.005. 
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SUPPLEMENTAL FIGURES 
 
 
 
Figure S3.1 Distribution of Sel1L protein level in MKO mouse model.  
(A) Sel1L protein levels in different adult mouse tissues. (B) Collected bone 
marrow cells from WT and MKO mice were cultured and stimulated by 
macrophage colony-stimulating factor (M-CSF) by a time course. Sel1L protein 
levels were shown in the western blot and the quantification was shown below. 
Hsp90, a loading control. 
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Figure S3.2 Normal spleen T cell and B cell population in naïve WT and MKO 
mice.  
Naïve (A) or Thioglycollate-injected mice (B) spleens were dissected and 
analyzed by FACS. CD4 and CD8 antibodies were used to gate and quantify the 
percentage of T cells; B220 and CD69 were used to gate and quantify the 
percentage of B cells; CD11b and F4/80 antibodies were used to gate and quantify 
the percentage of macrophages. CD11b and Gr1 were used to gate and quantify 
the percentage of myeloid cell lines. (N=7 each and 2 repeats for CD4+, CD8+, 
B220+ FACS; N=4 each for F4/80+, Gr1+ FACS) 
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Figure S3.3 Normal Mitochondria number and morphology in MKO peritoneal 
macrophages.  
Representative transmission electron microscopy (TEM) images of peritoneal 
macrophages are shown here. The scale bars were shown in the picture, with 
arrows indicating mitochondria and N indicating nucleus. Quantifications were 
shown on the right side. 
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Figure S3.4 UPR genes in MKO peritoneal macrophages.  
Peritoneal macrophages were cultured and treated in the conditions as listed 
above. Q-PCR was performed to show relative UPR gene expression levels in 
both the WT and MKO peritoneal macrophages. 
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Figure S3.5 Accumulation of IRE1α and PERK by blocking cytosolic 
proteasomes. 
Peritoneal macrophages were collected and cultured overnight, then treated 
with MG-132 (1mM) for the indicated time course. Western blots showed the 
protein levels of IRE1α and PERK. Hsp90 was a loading control. Quantifications 
were shown below. 
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Figure S3.6 The half-life of UPR and ERAD component proteins in MKO 
macrophages.  
Peritoneal macrophages were collected and cultured overnight, then treated 
with cycloheximide (CHX) (100µg/ml) for indicated time points. Western blots 
showed the protein levels of UPR and ERAD components. Hsp90 was a loading 
control. Quantifications of half-lives were shown below. 
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Figure S3.7 MKO peritoneal macrophage inflammatory response model in vitro. 
(A) Sel1L protein levels under the stimulation of various TLR agonists were 
indicated in the western blots. (B) Peritoneal macrophages were treated with LPS 
(1000ng/ml) by the indicated time points. P-JNKs were shown in the western blot. 
Hsp90 was a loading control. Quantification of p-JNK normalized to hsp90 was 
shown below. 
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Figure S3.8 P2X7 levels in MKO peritoneal macrophages.  
Peritoneal macrophages were treated with 0.1 µg/ml LPS for 5 h followed by 
addition of 5 mM ATP for 30 min. Intracellular and cellular surface P2X7 levels 
with or without the treatment were measured by the flow cytometer. 
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3.5 DISCUSSION 
 The link between ER homeostasis, UPR and inflammation is an emerging 
paradigm for the inflammatory responses in many disease settings. The prevailing 
view that the ERAD functions as a critical regulator of cellular function is based 
largely on the premise that ERAD deficiency causes an accumulation of 
misfolded proteins, perturbs ER homeostasis and stimulates ER stress response. 
However, the physiological significance of ERAD pathways and the necessity of 
a particular ERAD pathway in the normal cellular function of a specific cell type 
remain largely unknown.  
 
A recent study using liver-specific gp78 (a membrane-anchored ubiquitin 
ligase and main component of gp78 ERAD complex) knock-out mice showed that 
gp78 mediated the degradation of HMGCR via Insig proteins and ER stress is not 
activated based on chaperone GRP78 protein levels (381). By contrast, our 
present data in macrophages demonstrate that Sel1L deficiency significantly alters 
ER homeostasis with elevated protein levels of IRE1α and a subset of chaperones. 
Nonetheless, we believe that the Sel1L-deficient macrophages have adapted to the 
loss of the SelL-Hrd1 ERAD function through the function of UPR, thus 
rendering cells with very modest ER stress as judged by direct sensor 
phosphorylation (IRE1α and PERK) and Xbp1 mRNA splicing (Figure 3.3). 
Indeed, compared to WT cells, MKO macrophages have significantly increased 
ER volume with dilated ER cisternae while cell apoptosis is normal under basal 
culture conditions. This suggests alterations of ER homeostasis and successful 
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cellular adaptation. The notion of cellular adaptation is further supported by both 
in vitro and in vivo studies of macrophage functions: innate responses to LPS 
shock, pathogen infection (cytokine release and survival), inflammasome 
activation and inflammation related to obesity were completely normal. 
Furthermore, using the phos-tag approach, we showed that although total IRE1α 
protein is dramatically increased, IRE1α in MKO macrophages are only slightly 
hyperphosphorylated. Consistently, Xbp1 mRNA splicing is only slightly 
upregulated in MKO macrophages. These observations were supported by recent 
in vitro studies where no-to-low UPR activation was noted in Sel1L-knockdown 
HeLa cells (186, 382). Collectively, these and our data suggest cellular adaptation 
to Sel1L and ERAD deficiency.  
 
Our data provided direct and strong evidence that Sel1L plays a critical role in 
ERAD function, as indicated by previous elegant biochemical studies (166, 196, 
345, 350). However, whether Sel1L function in vivo is exclusively mediated 
through the Hrd1 ERAD complex remains unknown. Earlier in vitro studies have 
shown that in the absence of Sel1L, Hrd1-mediated degradation of model 
substrate antigens such as T-cell receptor (TCR), mutant transthyretin (TTRD18G) 
and null Hong Kong variant of α1-antitrypsin (A1ATNHK) is attenuated. 
Interestingly, a recent study showed that the Hrd1 substrate glutamate receptor 
subunit (GluR1) may be Sel1L-independent (345), suggesting that Sel1L may not 
be involved in the degradation of all Hrd1 substrates. On the other hand, Sel1L 
may have Hrd1-independent functions as it has been reported that not all Sel1L is 
associated with Hrd1 (135, 383, 384). Nonetheless, proteomic analyses from two 
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laboratories in HEK293T and HeLa cells have identified a number of Sel1L-
interacting proteins, most of which are involved in the ERAD function (166, 345, 
350). This list includes Hrd1 and p97, key components of ERAD; and OS-9 and 
XTP-3B, two lectins that help define substrate specificity for the ERAD complex. 
More studies are required to determine whether other aspects of macrophage 
function, such as iron metabolism, are impaired in MKO mice and whether Sel1L 
has additional ERAD-independent functions. The identification of bona fide 
Sel1L-Hrd1 substrates in macrophages will help address these questions.   
 
Our data showed that both IRE1α and PERK protein levels are dramatically 
elevated in Sel1L-deficient macrophages, although IRE1α phosphorylation and 
RNase activity are not.  The increase of IRE1α protein has also been observed, 
albeit to a much lesser extent, in Derlin 2- and XBP1- deficient cells (222, 364). 
Whether IRE1α and PERK are direct substrates of the Sel1L-Hrd1 ERAD 
complex remains to be demonstrated. Moreover, unlike that in Sel1L-deficient 
macrophages, IRE1α in XBP1-deficient hepatocytes is hyperphosphorylated with 
elevated IRE1α RNase activity (222). The authors proposed that this might be due 
to the negative feedback regulatory mechanism of IRE1α by XBP1s. Thus, the 
difference in IRE1α activity between Sel1L- and XBP1-deficient cells may be due 
to the different levels of XBP1s proteins.  In addition, unlike our MKO mice, 
mice with macrophage-specific deletion in Xbp1 gene are defective in 
inflammatory responses against LPS challenges and bacterial infections (298). 
Mechanistically, Martinon et al. (2010) showed that the TLR signaling synergizes 
with the IRE1α-XBP1 pathway, in part through XBP1s-mediated transcriptional 
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regulation of various inflammatory cytokines.  Thus, the Sel1L MKO mouse 
model is not equivalent to the UPR sensor- or effector- null mouse models, as in 
MKO mice, the three UPR branches are intact thus allowing them to respond 
efficiently to the disturbance of ER homeostasis. 
 
Why MKO macrophages and mice showed no defects in immunity functions 
could also be explained by multiple compensatory mechanisms: First, increases in 
the levels of chaperones and ER volume via the UPR pathway could explain this 
phenomenon. Second, the function of Sel1L/HRD1 ERAD complex could also be 
compensated for by other ERAD complexes (385). And third, increased 
autophagy functions or other proteasome pathways could compensate for the 
defect of ERAD function. Another possibility is the existence of macrophage 
specific Sel1L isoforms. Currently, there are five predicted isoforms of Sel1L 
based on computational predictions and experimental confirmations: 
Sel1LA/B/C/D/E (348). These isoforms are the result of alternative splicing. 
Although none of the predicted sizes of known Sel1L isoforms match the lower 
bands found on the Sel1L western blot, there is still a possibility that macrophage-
specific Sel1L variants may exist. These isoforms may not be completely knocked 
out by the Flox-Cre system. It could be an isoform with a random start codon after 
the exon 6, or it could be an isoform that skips the exon 6. Thus, more research 
needs to be performed to identify the mechanisms for these unexpected results, 
which show that Sel1L is dispensable for macrophages immunity functions. 
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 Sel1L is ubiquitously expressed in tissues and most abundantly in 
secretory organs such as the pancreas. Although the Sel-1 null worm and Hrd3 
deficient yeast are viable, whole body Sel1L knock out mice are embryonic lethal 
(352). The embryos did not survive embryonic day e14.5, indicating a critical 
developmental stage that requires the Sel1L function. Whether this is related to its 
ERAD function or other functions such as the Notch signaling pathway remains 
unclear. Interestingly, in addition to two isoforms of Sel1L, there are two 
homologs of Sel1L in mice and humans: Sel1L2 and Sel1L3 
(http://genome.ucsc.edu). The functions of these two homologs are completely 
unknown. As Sel1L2 shares more than a 50 percent identity with Sel1L and is 
predicted to be a transmembrane protein, it may be able to compensate for Sel1L 
ERAD function in the absence of Sel1L. Further characterization of tissue-
specific functions of Sel1L and its isoforms may help identify the importance of 
Sel1L in various cell types in vivo. 
 
We have concluded that although Sel1L deficiency disrupts a key ERAD 
function, it does not result in a sustained UPR. This is probably due to the 
compensatory function of other quality-control systems that allow adaptation to 
Sel1L knock out. In other words, Sel1L-deficient cells have re-set their ER 
homeostasis, also known as “proteostasis” (386, 387). Whether this is true in cell 
types other than macrophages or tissues remains to be seen.  It is also interesting 
to note the similarities between our macrophage-specific Sel1L-deficient mice 
and mice with Derlin 2 deficiency, specifically in hepatocytes and B cells where 
the increased protein levels of several chaperones and IRE1α were noted (364).  
  
 
 
 
 
161 
3.6 ACKNOWLEDGEMENTS 
We thank Drs. Cindy Leifer, H. Ploegh and M. Freeman for reagents and 
antibodies; John L. Grazul for assistant in TEM analysis; and members of the Qi 
Lab for technical assistance and discussions. This study is supported by NIH 
R01DK082582, ADA 07-08-JF-47 and 1-12-CD-04 (L.Q.). 
 
AUTHOR CONTRIBUTIONS   
Z.X. designed and performed most experiments, revised the manuscript; Y.J. 
performed flow cytometric analysis of ER mass, immunotyping in adipose tissue 
and spleen, and assisted with in vivo study in LPS study; S.S. performed Q-PCR 
and assisted with some in vivo studies; H.K. performed surface MHC class I/II 
analysis and T cell activation in vitro; H.M. performed the Listeria infection 
study; Q.L. provided the floxed mice; L.Q. designed the experiments and wrote 
the manuscript. Everybody analyzed data and commented on the manuscript. 
 
COMPETING FINANCIAL INTERESTS    The authors declare no 
competing financial interests. 
  
 
 
 
 
162 
Chapter 4 SUMMARY AND FUTURE DIRECTIONS 
It has been concluded that the unfolded protein response plays an important 
role in maintaining cell ER protein homeostasis. IRE1α, PERK and ATF6, the 
three major UPR pathways, respond to ER stress by up-regulating protein folding 
capacity, global translation attenuation and enhancing ER protein degradation. 
The activation of the UPR pathways is tightly regulated under various 
physiological and pathological conditions in a both tissue specific and temporally 
specific manner, depending on the kind of stimulation received. The UPR plays 
an essential role, not only in normal developmental process, but also in metabolic 
diseases such as obesity and diabetes, cardiovascular diseases, cancer, 
neurodegenerative diseases and immune diseases. Therefore, it is desired, yet 
challenging, to dissect the UPR pathways under variable conditions. At the same 
time, the molecular mechanism of UPR regulation is also of importance for 
further research into new therapies that target UPR pathways. 
 
 This thesis focused on both the physiological functions of ERAD and on the 
molecular mechanisms of UPR activation. In Chapter 2, a highly conserved 
proline residue at IRE1α position 830 (P830) was determined to be critical for 
IRE1α structural integrity, as well as the activation of both kinase and RNase 
domains.  Structural analysis revealed that P830 may form a highly conserved 
structural linker with adjacent tryptophan and tyrosine residues at positions 833 
and 945 (W833 and Y945), thereby bridging the kinase and RNase domains. 
Mutation of P830 to leucine (P830L) completely abolished the kinase and RNase 
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activities, thus significantly decreasing protein stability and preventing 
oligomerization of IRE1α upon ER stress.  
 
Besides the individual amino acid residue functions and inner-molecule or 
inter-molecule interactions, there are several other aspects to be further studied for 
a better understanding of the molecular mechanism of IRE1α activation.  
 
1) IRE1 is known to interact with multiple cofactors to facilitate diversified 
downstream effects. For example IRE1-TRAF2-ASK1 complex activates the JNK 
pathway (131), and IRE1α-TXNIP activates the NLRP3 inflammasome and 
terminal UPR pathway to induce apoptosis (339). Certain cofactors are also 
required to resolve IRE1α activation; e.g. nonmuscle myosin heavy chain IIB is 
required for IRE1α aggregation and foci formation. It is likely there are more 
interactive proteins associated with IRE1α to regulate its activation function, 
particularly in a tissue-specific manner. Therefore, in future research, I propose to 
perform IRE1α Immunoprecipitation in different detergent buffers. Further, I will 
perform protein mass spectrometry to identify more interacting proteins with 
IRE1α and then use specific knock-out or overexpression model to study the 
relevant biological functions.  
 
2) Based on IRE1α kinase activation, RNase domain of IREα will undergo 
conformational change and cleave the mRNA XBP1u to form XBP1s. However, 
it is still not clear how XBP1u is recruited to IRE1α and whether there is cross-
talk between IRE1α sensor and XBP1 trafficking. On the other hand, it’s not clear 
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yet how the cleaved XBP1s regulate the negative feedback to suppress IRE1α. 
Understanding the cross-talk between IRE1α-XBP1 is essential for further 
manipulating of this pathway.  
 
3) Under ER stress conditions, IRE1α mRNA and total protein levels are not 
significantly increased (Fig S3.4). This indicates a fast reaction based on 
phosphorylation and conformational change. Chemical compounds are now being 
developed to modulate the signaling output from IRE1α. For yeast IRE1α, Papa 
first made a L745G mutant IRE1α which, while bypassing the kinase activity and 
phosphorylation, can constitutively activate all downstream functions at the 
presence of ATP-competitive inhibitor 1NM-PP1 through conformational change 
in the kinase domain (320). In addition, ADP, APY29, Cdk1/2 inhibitor III, and 
JAK inhibitor 1 all bound the IRE1α cytosolic domain and help conformational 
change in back-to-back dimers, which correlates with stimulation of IRE1 
nuclease activity (388). More importantly, these chemical compounds need to be 
studied in mammalian IRE1α, as mammalian IRE1α are able to form high order 
oligomers (334), indicating a slightly different activation mechanism. I would 
propose to work on the crystal structure of mammalian IRE1α structure, test the 
compatibility of chemical compounds and identify new ones for drug discovery.  
 
4) In Sel1L knock-out macrophages, we observed more than a ten-fold 
increase in IRE1α protein levels. It was indicated in the previous research that 
IRE1α is degraded through HRD1 (389). Data in Chapter 3 also suggested a 
possibility that Sel1L regulates the IRE1α degradation by HRD1. Therefore I 
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propose in future research to delineate the relative role of Sel1L, HRD1, Derlin1 
or Derlin2, and other interaction proteins facilitating IRE1α degradation. It is 
interesting that the increase in phosphorylated forms of IRE1α is much less than 
the total IRE1α protein accumulation. This indicates that the constitutive 
dephosphorylation process was increased. Whether Sel1L regulates the IRE1α 
dephosphorylation process is still unknown. 
 
In chapter 3, the physiological role of Sel1L in macrophage innate 
immunology was studied. Although ERAD plays an important role in maintaining 
ER protein homeostasis, and previous research has shown a close link between 
UPR activation and inflammatory response (reviewed in chapter 1.5.2), 
surprisingly our results showed that Sel1L is dispensable for macrophage immune 
functions including antigen presentation, cytokine secretion, pathogen defense 
and mild inflammatory response in metabolic diseases. This indicates 
compensatory mechanisms exist to cope with Sel1L defects. For future study, I 
propose to focus on possible compensatory mechanisms. This is important 
because it helps us understand the cross-talk between ERAD and UPR pathways, 
as well as the tissue specific function of ERAD, since other tissue Sel1L knock-
out models in our lab showed different defective phenotypes. 
 
The first hypothesis is that other mammalian ERAD E3 complex compensates 
for Sel1L knock-out and a decrease in HRD1 protein level. Secondly, it is 
possible that the overall process of protein transportation, from the ER to the 
Golgi and then to lysosome or extracellular, is enhanced. Third, it could be the 
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activation of autophagosomes. Fourth, other protein degradation pathways such as 
a proteasome system in the nuclear could compensate for protein degradation. 
And fifth, it could be that in macrophages there are no important physiological 
substrates that are strictly dependent on Sel1L-HRD1 degradation. Therefore, 
future study could utilize different antagonists to block individual compensatory 
pathways to identify the most important ones. For example 3-Methyladenine (3-
MA) could be used to block autophagy (390), MG-132 to block the proteasome, 
the downstream common pathway of ERAD, and Eeyarestatin to inhibit P97 
(391). Identification of compensatory pathways will reveal the overall protein 
degradation cross-talk in macrophages. 
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